Artificial skin comprising fibrous mat

By using a water-insoluble porous shell to encapsulate hydrophilic polymers and cells in the electrospun fiber mat, combining water-tight containers and activation compositions, the fiber integrity and shelf life of the fiber mat under high loads is solved, and cells are achieved long-term vitality and metabolite generation.

CN119013004APending Publication Date: 2024-11-22NANOSPUN TECHNOLOGIES LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380026594.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-12-22
Filing Date
2023-01-11
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing electrospun fiber mats that encapsulate cells are difficult to maintain fiber integrity under high loading conditions and cannot effectively provide long shelf life living cells for skin care.

Method used

Multiple electrospun fibers are used, each fiber includes a shell that encapsulates the core, the core contains hydrophilic polymer and multiple cells, the shell is a water-insoluble porous shell with a load of up to 1013CFU/cm2, and the thickness of the fiber cushion is 10 to 10. Between 2000 um, dormant cells are contained, with a water content of less than 10%, and are equipped with a watertight container for activation and an activation composition.

Benefits of technology

The stable encapsulation of high load cells is achieved, which extends the cell viability retention time, ensures the mechanical strength and shelf life of the fibers, and activates cells under appropriate conditions to generate skin metabolites.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119013004A_ABST
    Figure CN119013004A_ABST
Patent Text Reader

Abstract

A fibrous mat is provided that includes a plurality of electrospun fibers wherein each electrospun fiber includes an outer shell and a core that includes a water-soluble polymer and a plurality of cells, such as dormant cells or viable cells. Further provided are methods of activating dormant cells and methods of use thereof, e.g., for supplementing cosmeceutical ingredients to the skin of a subject.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application is a PCT international application, claiming priority to U.S. patent application No. 63 / 298,549 filed on January 11, 2022 and U.S. patent application No. 63 / 434,805 filed on December 22, 2022, which are hereby incorporated by reference into this application in their entirety. Technical Field

[0003] The present invention, in some embodiments thereof, relates to a fiber mat encapsulating viable cells and the preparation and use thereof. Technical Background

[0004] Electrospun fiber mats encapsulating cells have been previously disclosed. However, there remains an unmet need to encapsulate very high loadings of cells in fibers while maintaining fiber integrity.

[0005] As a non-limiting example, the biologically active ecosystem of the skin, the bacteria residing on human skin, is referred to as the skin microbiome, and its presence and activity are essential to protecting and supporting skin health, including enhancing skin hydration and elasticity, preventing skin sensitivity and redness, reducing wrinkles, and aiding in anti-aging effects. However, the human skin microbiome is constantly being damaged by the environment. In addition, exposure of the skin to various skin care products also poses a threat to the skin microbiome, thereby affecting skin health. For this reason, there are no useful solutions that provide an effective number or concentration of live / viable microbial cells sufficient for implementation in skin and / or topical care.

[0006] Thus, there is an unmet need for a user-friendly skin care product that has a long shelf life and includes an effective amount of viable cells that can be easily activated in situ prior to application thereof to human skin. Summary of the invention

[0007] In one aspect of the present invention, a fiber mat is provided, comprising a plurality of electrospun fibers, wherein each electrospun fiber comprises a shell encapsulating a core, wherein the fiber mat is characterized by a thickness between 10 and 2000 um; and the core comprises a hydrophilic polymer and a plurality of cells.

[0008] In another aspect of the present invention, a fiber mat is provided, comprising a plurality of electrospun fibers, wherein each electrospun fiber comprises a shell encapsulating a core, wherein: the fiber mat is characterized by a thickness between 10 and 2000 um; the core comprises (i) a water-soluble material comprising a water-soluble polymer, and (ii) a plurality of cells; the shell is a porous shell comprising a water-insoluble polymer; and wherein the loading of the plurality of cells within the fiber mat is at most 10 13 CFU / cm2 .

[0009] In one embodiment, the plurality of cells are selected from microbial cells, microbial spores, microorganisms or combinations thereof; optionally, the microbial cells or microbial spores include one or more bacteria, fungi or both. In one embodiment, the cells are selected from microbial cells, microbial spores or both. In one embodiment, the cells are dormant cells. In one embodiment, the cells are living cells.

[0010] In one embodiment, the fiber mat is formable and configured to substantially assume the shape of an application site and remain at the application site for a predetermined period of time.

[0011] In one embodiment, the dry weight / weight (w / w) concentration of dormant cells in the mat is at most 95%. In one embodiment, the dry weight / weight concentration of dormant cells in the mat is at most 90%. In one embodiment, the dry weight / weight concentration of dormant cells in the mat is at most 80%.

[0012] In one embodiment, the average cross-section of the electrospun fibers is between 1 and 500 um. In one embodiment, the average cross-section of the electrospun fibers is between 1 and 300 um. In one embodiment, the average cross-section of the electrospun fibers is between 1 and 200 um. In one embodiment, the average cross-section of the electrospun fibers is between 1 and 100 um.

[0013] In one embodiment, the loading amount of the plurality of cells in the fiber mat is 10 9 and 10 12 CFU / cm 2 between.

[0014] In one embodiment, the fiber mat consists essentially of a biocompatible material, a cosmeceutical grade material, or a medical grade material, wherein the shell is a solid porous shell comprising a hydrophobic polymer comprising a fluoropolymer, including any copolymers thereof.

[0015] In one embodiment, the water-insoluble polymer includes a water-insoluble polysaccharide, a fluoropolymer, or PVDF-HFP, including any combination and any copolymer thereof.

[0016] In one embodiment, the water-insoluble polysaccharide comprises cellulose, a water-insoluble cellulose derivative, including any combination and any copolymer thereof. In one embodiment, the water-insoluble cellulose derivative comprises cellulose acetate, cellulose acetate phthalate, methyl cellulose, ethyl cellulose, ethyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, hydroxypropyl methyl cellulose, including any combination and any copolymer thereof.

[0017] In one embodiment, the water-soluble polymer is selected from water-soluble polysaccharides, polyols, polyvinyl alcohol, polyalkylene oxide, PVP, polyether, including any copolymers and any combination thereof.

[0018] In one embodiment, the shell comprises up to 90% (by weight) of a hydrophobic polymer, wherein the hydrophobic polymer comprises PVDF-HFP and / or cellulose.

[0019] In one embodiment, the shell consists essentially or entirely of a natural polymer.

[0020] In one embodiment, the fiber mat is characterized by adhesion to human skin, wherein the fiber mat is in moist form.

[0021] In one embodiment, the microbial cells include one or more bacteria, yeast, fungi or any combination thereof. In one embodiment, the microbial cells include probiotics.

[0022] In one embodiment, the fiber mat further comprises a plant extract, a bacterial metabolite, a fungal metabolite, a yeast metabolite, or any combination thereof.

[0023] In one embodiment, the fiber mat is characterized by a moisture content of less than 10%, and wherein dormant cells remain viable within the mat for at least 7 days, at least 14 days, or at least 30 days.

[0024] In one embodiment, the fiber mat is characterized by a water absorption capacity of at least 100% relative to the dry weight of the fiber mat.

[0025] In one embodiment, the fiber mat is in the form of a uniform layer of nonwoven fabric.

[0026] In one embodiment, the fiber pad is in the form of a topical product, eg, configured for application to a target site on the skin of a subject.

[0027] In one embodiment, the fiber mat may be used in any of the cosmeceutical, cosmetic, hygiene, and skin care applications.

[0028] In one embodiment, the topical product is further configured for subsequent removal from the target site, and wherein the topical product has sufficient mechanical strength to remain intact upon removal thereof.

[0029] In one embodiment, the topical product is configured to substantially adopt the shape of the target site.

[0030] In one embodiment, the topical product has a length dimension, a width dimension, or both that is substantially compatible with the dimensions of the target site or any portion thereof.

[0031] In one embodiment, the topical product is configured to stably adhere to the target site for a predetermined period of time.

[0032] In another aspect, a kit is provided comprising a fiber mat of the present invention packaged in a container, wherein the fiber mat is characterized by a moisture content of at most 20%, or at most 10%, and wherein the container wall is water impermeable and substantially oxygen impermeable.

[0033] In one embodiment, the container wall is stable at temperatures up to 60°C and is characterized by adequate heat conduction capabilities.

[0034] In one embodiment, the kit further comprises a watertight container comprising an activation composition, wherein the activation composition provides conditions for the dormant cells to return to an active state (eg, germination).

[0035] In one embodiment, the kit further comprises a watertight container comprising an activation composition, wherein the activation composition is capable of promoting living cells to secrete elements and / or metabolites, such as vitamins, acids and proteins.

[0036] In one embodiment, the activation composition is a liquid comprising an effective amount of a plant-based compound or plant extract, and optionally any of nutrients, minerals, sugars (monosaccharides, disaccharides, oligosaccharides and / or polysaccharides), surface active compounds or any combination thereof. In one embodiment, the activation composition is a natural composition.

[0037] In one embodiment, the activation composition is free of preservatives.

[0038] In one embodiment, the activating composition is characterized by a pH between 3 and 10.

[0039] In one embodiment, the effective amount is sufficient to activate dormant cells upon contacting the activating composition with the fiber mat under operable conditions.

[0040] In one embodiment, operable conditions include a temperature between about 15 and about 60°C. In one embodiment, operable conditions include a temperature between about 30 and about 60°C.

[0041] In one embodiment, the container wall defines a lumen configured to contain a volume of liquid.

[0042] In one embodiment, the container further comprises a seal, and wherein the seal is a removable seal or a breakable seal.

[0043] In one embodiment, the seal is characterized by an open state and a closed state.

[0044] In one embodiment, the seal is in the form of a valve, and wherein in an open state, the valve is configured to be in fluid communication with the watertight container and to support the flow of liquid from the watertight container into the lumen.

[0045] In one embodiment, the valve in the closed state is configured to seal the container.

[0046] In one embodiment, the fiber mat is placed in an inner container that is located within an outer container that includes the activation composition.

[0047] In one embodiment, the kit includes one or more additional compartments, for example, for containing designated pre-treatment and / or post-treatment solutions.

[0048] In one embodiment, the kit further comprises a heating device.

[0049] On the other hand, a method for in situ generation of cellular metabolites is provided, the method comprising contacting the fiber mat of the present invention with an activating composition under appropriate conditions sufficient to activate dormant cells and / or increase their activity, thereby inducing in situ generation of cellular metabolites; wherein the activating composition is a liquid, which includes liquids capable of causing dormant cells to enter an active state from a dormant state.

[0050] In another aspect, a method is provided, comprising providing a kit of the present invention, and contacting the fiber material of the kit with an activating composition of the present invention under appropriate conditions to obtain a topical product comprising a metabolite; and applying the topical product to a target area of ​​the subject's skin, thereby replenishing the skin with metabolites.

[0051] In one embodiment, the topical product comprises a pad in a moist state. In one embodiment, the topical product is a solution that is extracted and / or released from the pad.

[0052] In one embodiment, the activating composition comprises an effective amount of a plant-based compound or plant extract, and optionally, any of nutrients, minerals, sugars (monosaccharides, disaccharides, oligosaccharides and / or polysaccharides), surface active compounds, or any combination thereof.

[0053] In one embodiment, the activating composition includes an effective amount of a non-plant based compound.

[0054] In one embodiment, the activating composition is characterized by a pH between 3 and 10.

[0055] In one embodiment, contacting comprises soaking the fiber mat in the activating composition.

[0056] In one embodiment, suitable conditions include a temperature between about 15 and about 60°C. In one embodiment, suitable conditions include a temperature between about 30 and about 55°C.

[0057] In one embodiment, the topical product is provided in the form of a wet pad and / or a moist pad.

[0058] In one embodiment, the mat is degradable, such as by application to the skin of a subject.

[0059] In one embodiment, the mat may be composed of more than one type of fiber (ie, different types of fibers, each having specific properties, such as biological, chemical, and / or physical properties).

[0060] In some embodiments, the mat may include, for example prior to an activation step, active biomolecules including, but not limited to, enzymes, hormones, and growth factors.

[0061] In another aspect, a fiber mat is provided, comprising a plurality of electrospun fibers, wherein each electrospun fiber comprises a shell encapsulating a core, wherein the fiber mat is characterized by a thickness between 10 and 2000 um; the core comprises (i) a water-soluble material comprising a water-soluble polymer, and (ii) a plurality of cells; and the shell is a porous shell comprising a water-insoluble polymer; and wherein the loading of the plurality of cells within the fiber mat is at most 10 13 .

[0062] In one embodiment, the water-soluble polymer is selected from the group consisting of water-soluble polysaccharides, polyols, polyvinyl alcohol, polyalkylene oxides, PVP, polyethers, including any copolymers and any combination thereof.

[0063] In one embodiment, the water-insoluble cellulose derivative includes cellulose acetate, cellulose acetate phthalate, methyl cellulose, ethyl cellulose, ethyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, hydroxypropyl methyl cellulose, including any combination and any copolymer thereof.

[0064] In one embodiment, the water-soluble material further comprises monosaccharides, disaccharides, oligosaccharides or any combination thereof.

[0065] In one embodiment, the fiber mat is characterized by a water absorption capacity of up to 1000% relative to the dry weight of the fiber mat.

[0066] In one embodiment, the average cross-section of the electrospun fibers in the fiber mat is between about 10 and about 200 um; wherein the w / w concentration of the plurality of cells in the mat is at most 90%, or wherein the loading of the plurality of cells in the fiber mat is at most 10 12 CFU / cm2 ; wherein the shell comprises cellulose or a water-insoluble cellulose derivative; and wherein the core comprises (i) at least one of a monosaccharide, a disaccharide and an oligosaccharide; and (ii) a water-soluble polymer selected from polyalkylene oxides and water-soluble polysaccharides.

[0067] In another aspect, a fiber substrate is provided comprising polymeric fibers, each polymeric fiber being an electrospun fiber, comprising a shell encapsulating a core, wherein the core comprises a plurality of cells and a water-soluble material; the shell comprises a water-insoluble polymer; the average cross-section of the polymeric fibers is between 1 and 500 um; the loading amount of the plurality of cells in the fiber substrate is between 10 5 and 10 13 CFU / cm 2 between.

[0068] From the detailed description given below, further embodiments and the full scope of applicability of the present invention will become apparent. However, it should be understood that the detailed description and specific examples, although indicating preferred embodiments of the present invention, are given by way of illustration only, because various changes and modifications within the spirit and scope of the present invention will become apparent to those skilled in the art from this detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0069] Figure 1 is an image showing a schematic diagram of an exemplary kit comprising a dry fiber mat of the present invention within an airtight package in contact with an exemplary heating device.

[0070] Figure 2 are images illustrating exemplary fiber mats of the present invention.

[0071] Figure 3 is a SEM micrograph of an exemplary fiber mat of the present invention. DETAILED DESCRIPTION

[0072] In one aspect, a fibrous material (eg, a mat) in the form of a fiber matrix is ​​provided, wherein the fiber matrix comprises polymeric fibers, wherein the polymeric fibers are electrospun fibers comprising a hydrophobic (or water insoluble) porous shell and a hydrophilic (or water soluble) core.

[0073] On the other hand, a fibrous material is provided in the form of a fibrous matrix (such as a mat), wherein the fibrous matrix includes polymeric fibers and a plurality of cells encapsulated therein. In some embodiments, the fibrous material is in the form of one or more layers including a plurality of micron-sized polymeric fibers, wherein each polymeric fiber includes a polymeric shell encapsulating a core, wherein the core includes a plurality of living cells and / or dormant cells, and / or wherein the polymeric shell is a single-layer shell. In some embodiments, the polymeric shell is in direct contact with (or directly bonded to) the core. In some embodiments, the polymeric shell has no inner coating at the interface (interphase) between the core and the shell. In some embodiments, the fibrous material includes electrospun fibers or is substantially composed of electrospun fibers. In some embodiments, the w / w content of electrospun fibers in the fibrous material of the present invention is between 80 and 100%, between 85 and 99%, between 90 and 99%, between about 90 and 100%, including any ranges therebetween. In some embodiments, the fibrous material is in a solid state at a temperature of up to 100° C., up to 200° C., or higher.

[0074] As illustrated herein, the present invention, in some embodiments thereof, is based on the surprising discovery that specific core compositions of electrospun fibers are capable of supporting high loadings of viable cells such that the fiber mat encapsulates about 50% and up to about 95% viable cells (by dry weight of the fiber mat).

[0075] In some of its embodiments, the present invention is also based on the surprising discovery that the specific core composition of the electrospun fibers of the present invention can support a shelf life of at least one month under ambient conditions (such as between 10 and 30°C), or even longer under refrigerated conditions (such as between -20 and 5°C). In particular, the inventors have observed that by implementing a core electrospinning solution containing at least 0.5g / ml of a water-soluble polymer thickener (e.g., a monosaccharide and / or disaccharide, a water-soluble polysaccharide, or a water-soluble polymer), the electrospun microfibers have an extremely high encapsulated cell loading. In addition, it has been found that when stored in an airtight container, the core composition disclosed herein is conducive to maintaining the viability of the encapsulated cells for a period of at least about 1-3 months or longer. The encapsulated cells are then activated under appropriate conditions by integrating and / or soaking the dried mat with an activation solution. Cell activity has been assessed by monitoring the synthesis rate or concentration of cellular metabolites.

[0076] According to one aspect, a fiber mat comprises a plurality of electrospun fibers, wherein each electrospun fiber comprises a shell encapsulating a core, wherein: the fiber mat is characterized by a thickness between 10 and 2000 um; the core comprises (i) a water-soluble material comprising a water-soluble polymer, and (ii) a plurality of cells; the shell is a porous shell comprising a water-insoluble polymer; and wherein the loading of the plurality of cells within the fiber mat is at most 10 13 CFU / cm2 .

[0077] According to some embodiments, the plurality of cells are selected from microbial cells, microbial spores, microorganisms or a combination thereof; optionally, wherein the microbial cells or microbial spores include one or more bacteria, fungi or both.

[0078] According to some embodiments, the plurality of cells within the mat has a dry weight / weight (w / w) concentration of up to about 95%.

[0079] According to some embodiments, the w / w concentration of the plurality of cells in the mat is at most 90%, optionally wherein the plurality of cells are dormant cells.

[0080] According to some embodiments, the average cross-section of the electrospun fibers within the fiber mat is between 1 and 500 um. According to some embodiments, the average cross-section of the electrospun fibers within the fiber mat is between 10 and 300 um.

[0081] According to some embodiments, the loading amount of the plurality of cells in the fiber mat is 10 9 and 10 12 CFU / cm 2 between.

[0082] According to some embodiments, the fiber mat consists essentially of a biocompatible material or a cosmeceutical grade material.

[0083] According to some embodiments, the shell comprises at least 50% water-insoluble polymer (by dry weight), and optionally further comprises a water-soluble polymer.

[0084] According to some embodiments, the water-insoluble polymer includes a water-insoluble polysaccharide, a fluoropolymer, or PVDF-HFP, including any combination and any copolymer thereof.

[0085] According to some embodiments, the water-insoluble polysaccharide includes cellulose, water-insoluble cellulose derivatives, including any combination and any copolymers thereof.

[0086] According to some embodiments, the water-insoluble cellulose derivative includes cellulose acetate, cellulose acetate phthalate, methyl cellulose, ethyl cellulose, ethyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, hydroxypropyl methyl cellulose, including any combination and any copolymer thereof.

[0087] According to some embodiments, the water-soluble polymer is selected from the group consisting of water-soluble polysaccharides, polyols, polyvinyl alcohol, polyalkylene oxides, PVP, polyethers, including any copolymers and any combination thereof.

[0088] According to some embodiments, the water-soluble material further comprises monosaccharides, disaccharides, oligosaccharides or any combination thereof.

[0089] According to some embodiments, the fiber mat is formable and characterized by a water absorption capacity of up to 1000% relative to the dry weight of the fiber mat.

[0090] According to some embodiments, the fiber mat is in moist form and is characterized by adhesion to human skin.

[0091] According to some embodiments, the fiber mat further comprises a plant extract, a bacterial metabolite, a fungal metabolite, or any combination thereof.

[0092] According to some embodiments, the mat is characterized by a moisture content of less than 10%, and wherein the dormant cells remain viable within the mat for at least 3 months.

[0093] According to some embodiments, the average cross-section of the electrospun fibers in the fiber mat is between about 10 and about 200 um; wherein the w / w concentration of the plurality of cells in the fiber mat is at most 90%, or wherein the loading of the plurality of cells in the fiber mat is at most 10 12 CFU / cm 2 wherein the shell comprises cellulose or a water-insoluble cellulose derivative; and the core comprises (i) at least one of a monosaccharide, a disaccharide and an oligosaccharide; and (ii) a water-soluble polymer selected from polyalkylene oxides and water-soluble polysaccharides.

[0094] According to some embodiments, the water-soluble polysaccharide is a water-soluble gum, and wherein the polyalkylene oxide is PEG.

[0095] According to some embodiments, the fiber mat is in the form of a uniform layer of nonwoven fabric. According to some embodiments, the mat is in the form of a ball. According to some embodiments, the mat is in the form of a topical product configured for application to a target site on the skin of a subject.

[0096] According to some embodiments, the topical product is further configured to be subsequently removed from the target site, and wherein the topical product has sufficient mechanical strength to remain intact upon its removal.

[0097] According to some embodiments, the topical product is characterized by a tensile strength of at least 1 MPa.

[0098] According to some embodiments, the topical product is configured to substantially adopt the shape of the target site.

[0099] According to some embodiments, the topical product has a length dimension, a width dimension, or both that are substantially compatible with the dimensions of the target site.

[0100] According to some embodiments, the topical product is configured to stably adhere to the target site for a predetermined period of time.

[0101] According to another aspect, a kit is provided comprising a fiber mat of the present invention packaged in a container, wherein the fiber mat is characterized by a moisture content of less than 10% and the container walls are water impermeable and substantially oxygen impermeable.

[0102] According to some embodiments, the container wall is stable at temperatures up to 60° C. and is characterized by sufficient heat conduction capabilities.

[0103] According to some embodiments, the kit further comprises a watertight container comprising an activation composition, wherein the plurality of cells within the fiber mat are substantially in a dormant state, and wherein the activation composition is capable of causing the plurality of cells to enter an active state from the dormant state.

[0104] According to some embodiments, the activation composition is a liquid comprising an effective amount of a plant-based compound or plant extract, and optionally, any of nutrients, minerals, monosaccharides, disaccharides, oligosaccharides, polysaccharides, surface active compounds, or any combination thereof.

[0105] According to some embodiments, the activating composition is characterized by a pH value between 3 and 10.

[0106] According to some embodiments, the effective amount is sufficient to activate dormant cells upon contacting the activating composition with the fiber mat under operable conditions.

[0107] According to some embodiments, operable conditions include a temperature between about 30 to about 55°C.

[0108] According to some embodiments, the container wall defines a lumen configured to contain a volume of liquid; and wherein the container further comprises a seal; and wherein the seal is a removable seal or a breakable seal.

[0109] According to some embodiments, the seal is characterized by an open state and a closed state; wherein the seal is in the form of a valve, and wherein in the open state, the valve is configured to communicate with the fluid of the watertight container and support the flow of liquid from the watertight container into the tubular cavity, and wherein in the closed state, the valve is configured to seal the container.

[0110] According to some embodiments, the kit further comprises a heating device.

[0111] According to some embodiments, the kit further comprises instructions for contacting the fiber mat with the activating composition to obtain a moist mat and applying the moist mat to the skin of a subject.

[0112] According to some embodiments, the kit further comprises any of: (i) instructions for contacting the fiber mat with an activating composition to obtain a moist mat and applying the extract in the moist mat to the skin of a subject; and (ii) further comprising instructions for heating the moist mat, and wherein the heating is performed before or after skin application.

[0113] According to some embodiments, the heating is performed by a heating device.

[0114] According to another aspect, a method for in situ generation of cellular metabolites is provided, the method comprising contacting the fiber mat of the present invention with an activating composition under appropriate conditions sufficient to activate dormant cells, thereby inducing in situ generation of cellular metabolites; wherein the activating composition is a liquid, which includes liquids capable of causing dormant cells to enter an active state from a dormant state.

[0115] According to another aspect, a method is provided, comprising: providing a kit of the present invention, and contacting a fiber mat with an activating composition under appropriate conditions to obtain a topical product comprising a metabolite; and applying the product to a target site of a subject's skin, thereby replenishing the skin with metabolites.

[0116] According to some embodiments, the topical product comprises a pad in a wet state.

[0117] According to some embodiments, the activating composition comprises an effective amount of a plant-based compound or a plant extract, and optionally, any one of nutrients, minerals, sugars, surface-active compounds, or any combination thereof.

[0118] According to some embodiments, the pH of the activating composition is between 3 and 10.

[0119] According to some embodiments, contacting comprises soaking the fiber mat in the activating composition.

[0120] According to some embodiments, suitable conditions include a temperature between about 30 to about 55°C.

[0121] According to some embodiments, the suitable conditions include contacting the moist pad with (i) a heating device, (ii) the subject's skin, or both (i) and (ii).

[0122] According to some embodiments, the applying is under conditions sufficient to cause the temperature of the damp mat to reach between about 30 and about 55°C.

[0123] According to some embodiments, the providing is performed in situ on the skin of the subject.

[0124] According to some embodiments, the providing is by contacting the moist pad with a heating device, and wherein the contacting is performed in situ on the subject's skin.

[0125] According to another aspect, a fibrous substrate is provided comprising polymeric fibers, each polymeric fiber being an electrospun fiber comprising a shell encapsulating a core, wherein: the core comprises a plurality of cells and a water-soluble material; the shell comprises a water-insoluble polymer; the average cross-section of the polymeric fibers is between 1 and 500 um; and wherein the loading amount of the plurality of cells in the fibrous substrate is at least 100 μm per cm 2 10E5 units.

[0126] According to some embodiments, the water-soluble material comprises a water-soluble polymer selected from the group consisting of polysaccharides, polyols, polyvinyl alcohols, polyethers, and any combination thereof.

[0127] According to some embodiments, the water-soluble material further comprises monosaccharides, disaccharides, oligosaccharides or any combination thereof.

[0128] According to some embodiments, the w / w ratio of the shell to the core within the fiber is between 50:1 and 1:50, and wherein the dry w / w concentration of the plurality of cells within the fiber matrix is ​​between 40% and 98%.

[0129] According to some embodiments, the fibrous substrate is in the form of a fibrous mat.

[0130] According to some embodiments, the fiber mat is an electrospun mat characterized by a thickness between 10 and 2000 um.

[0131] According to some embodiments, the water-insoluble polymer is selected from cellulose, fluoropolymers, PVDF-HFP, PVP, PCL, PLA, PGA, polystyrene, PES, acrylate polymers, water-insoluble polysaccharides, water-insoluble cellulose derivatives, including any combination and any copolymers thereof.

[0132] According to some embodiments, the water-insoluble polymer comprises at least 50% of the shell by dry weight; and wherein the shell is characterized by a plurality of pores characterized by an average pore size between 10 and 500 nm.

[0133] According to some embodiments, the shell is characterized by a thickness between 10 nm and about 10 um.

[0134] According to some embodiments, the water-insoluble polymer is characterized by a solubility of at least 5% w / w in a solvent selected from the group consisting of THF, DMF, acetone, DMAC, chloroform, DMSO, DCM, NMP, TCE, TFE, butanol, methanol, ethanol, HFP, isopropanol, ethyl acetate, ethanolamine, pentane, ethylene glycol, diethyl ether, butyronitrile, acetonitrile, chlorobenzene, including any combination thereof.

[0135] According to some embodiments, the core further comprises at least one additional ingredient selected from active ingredients, cell nutritional ingredients, or both.

[0136] According to some embodiments, the viability of the plurality of cells within the polymeric fibers can be maintained for at least 2 weeks.

[0137] As used herein, the term "matrix" refers to one or more porous layers of polymeric fibers randomly and / or in a certain order or controlled distribution therein. In some embodiments, the terms "fibrous material" and "matrix" are used interchangeably herein. The matrix may further include any material incorporated into the layer and / or inserted between the layers. In some embodiments, the matrix includes randomly oriented polymeric fibers. In some embodiments, each polymeric fiber in the matrix is ​​in contact with at least one other polymeric fiber. In some embodiments, the polymeric fibers are randomly distributed in the matrix to obtain a three-dimensional network structure including gaps between the fibers. In some embodiments, the polymeric fibers are randomly distributed in the matrix to form a plurality of pores (or gaps).

[0138] In some embodiments, the terms "layer" and "film" are used interchangeably herein and refer to a material having substantially uniform thickness. In some embodiments, the term "layer" refers to a substantially homogeneous material characterized in that the chemical composition is substantially the same and / or the three-dimensional structure is substantially the same. In some embodiments, the layer is characterized in that there is a uniform or uniform feature throughout the layer, wherein the feature is selected from the spatial distribution of polymeric fibers, fiber thickness, pore size, porosity, thickness, including any range therebetween. In some embodiments, the term "entire layer" refers to at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97% of the layer surface and / or layer volume, including any range therebetween.

[0139] The terms "hydrophilic polymer" and "water-soluble polymer" are used interchangeably herein. The terms "hydrophobic polymer" and "water-insoluble polymer" are used interchangeably herein. The terms "porous shell" and "shell" are used interchangeably herein and refer to the exterior of the polymeric fiber of the present invention that faces the environment and closes or encapsulates the core.

[0140] "Hydrophilic core" and "core" are used interchangeably herein and refer to the interior portion of the polymeric fibers of the present invention that is in direct contact with and encapsulated by the outer shell.

[0141] In some embodiments, the fibrous material is in the form of a fiber mat. In some embodiments, the fiber mat is in the form of a nonwoven fabric layer. In some embodiments, the fiber mat is in the form of a layer characterized by relatively uniform thickness, uniform spatial distribution of polymeric fibers, or both. In some embodiments, the polymeric fibers are electrospun fibers (such as electrospun microfibers). In some embodiments, the polymeric fibers have a cylindrical shape or a barrel-like shape (such as a hollow tube).

[0142] In some embodiments, cells and / or spores are encapsulated by the polymeric shell of polymeric fibers, wherein at least 70%, at least 80%, at least 85%, or between 60 and 95%, between 70 and 100%, between 70 and 95% of the initial amount of encapsulated cells and / or spores remain viable for at least 2 weeks, at least 1 month, 1 year, or even longer.

[0143] Polymer Fiber

[0144] In one aspect, the present invention provides a polymeric fiber (e.g., an electrospun microfiber) comprising a porous shell encapsulating, enclosing, and / or directly contacting a hydrophilic core. In some embodiments, the polymeric fiber of the present invention is an electrospun fiber. In some embodiments, the polymeric fiber of the present invention consists essentially of electrospun fibers (e.g., electrospun microfibers). In some embodiments, the porous shell is as described herein, and the hydrophilic core comprises a plurality of cells and / or a plurality of spores and a water-soluble material, wherein the water-soluble material constitutes up to 50%, up to 40%, up to 30%, up to 20%, up to 15%, up to 10%, up to 5%, up to 3%, up to 2%, up to 1%, up to 0.5%, up to 0.2%, between about 0.1% and about 20%, between about 0.2% and about 25%, between about 0.2% and about 30%, between 1% and 20%, between 2% and 20%, between 5% and 20%, between 10% and 20%, between 5% and 15%, between 5% and 10%, including any ranges therebetween, of the polymeric fibers by dry weight.

[0145] In some embodiments, the water-soluble material is a thickener. In some embodiments, the water-soluble material is or includes a water-soluble polymer. In some embodiments, the water-soluble material is or includes a monosaccharide, a disaccharide, an oligosaccharide, or any combination thereof. In some embodiments, the water-soluble material includes a sugar (e.g., a sugar as disclosed herein) and a hydrophilic polymer as disclosed herein, wherein on a dry weight basis, the w / w concentration of the water-soluble polymer constitutes at most 20%, at most 15%, at most 10%, at most 5%, at most 3%, at most 2%, at most 1%, at most 0.5% of the hydrophilic core, including any range therebetween. In some embodiments, the water-soluble polymer is a thickener or a filler. In some embodiments, the porous shell of the polymeric fiber is a solid (or a solid porous shell); and wherein the hydrophilic core is in a solid or semi-solid state.

[0146] In some embodiments, the water-soluble material comprises a single type of water-soluble polymer and / or a single type of sugar. In some embodiments, the water-soluble material comprises multiple chemically different types of water-soluble polymers, and / or multiple. In some embodiments, the water-soluble material comprises multiple chemically different types of sugars.

[0147] In some embodiments, the water-soluble polymer can change the viscosity of the electrospun core solution, so as to obtain a predetermined viscosity sufficient to form the electrospun fiber of the present invention. In some embodiments, the water-soluble polymer includes a water-soluble polysaccharide, a polyalkylene oxide (such as polyethylene glycol (PEG), polypropylene glycol (PPG)), a polyol, a polyvinyl alcohol (PVA), a polyether, a polyvinyl pyrrolidone (PVP) or any combination thereof. In some embodiments, the water-soluble polymer is or includes a polysaccharide. Many water-soluble polysaccharides suitable for implementation in the polymerized electrospun fiber core are known in the art. Exemplary water-soluble polysaccharides and other polymers suitable for making polymerized electrospun fibers are listed in WO2008 / 041183, which is incorporated herein by reference in its entirety.

[0148] Non-limiting examples of water-soluble polysaccharides include, but are not limited to, water-soluble derivatives of cellulose (e.g., carboxylated cellulose, such as HPMC), alginic acid, hyaluronic acid, chitosan, water-soluble gums (e.g., guar gum, locust bean gum, gellan gum, xanthan gum, acacia gum, gum Arabic), carrageenan (e.g., λ-carrageenan), including any copolymers, or any combination thereof.

[0149] In some embodiments, the core further comprises an active ingredient (e.g., a pharmaceutically active agent, a cosmeceutical active agent, a nutraceutical, or any combination thereof). In some embodiments, the core further comprises a cell nutrient component (e.g., dried culture medium components, such as growth factors, carbohydrates, cofactors, etc.).

[0150] In some embodiments, the core of the polymeric fiber of the present invention is mainly composed of water-soluble materials and a plurality of cells, wherein the water-soluble materials include or are mainly composed of water-soluble polymers and sugars. In some embodiments, between 70% and 100%, between 70% and 95%, between 80% and 99%, between 90% and 99%, between about 90% and 100% of the water-soluble materials in the polymeric fiber of the present invention are composed of water-soluble polymers and sugars.

[0151] In some embodiments, the core is a uniform core comprising a matrix composed of polymeric chains intertwined with each other by water-soluble polymers and sugars. In some embodiments, sugars and water-soluble polymers are uniformly mixed or distributed in the core. In some embodiments, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 70%, at least 90%, at least 95% of the volume of the polymeric fiber is filled with core components, including any range between the two. In some embodiments, at least 10%, at least 20%, at least 30%, at least 40%, at least 50%, at least 70%, at least 90%, at least 95% of the core is empty, including any range between the two. In some embodiments, polymeric fibers in which at least 30% or more of the core is void are referred to herein as hollow tubular structures.

[0152] In another aspect, a polymeric fiber (e.g., an electrospun microfiber) is provided, comprising or encapsulating a plurality of cells, a plurality of spores, or both; wherein the polymeric fiber comprises a porous hydrophobic shell and a hydrophilic core, and wherein the hydrophilic core comprises or encapsulates a plurality of cells and a water-soluble material; and wherein the porous hydrophobic shell comprises or consists essentially of a water-insoluble polymeric material. In some embodiments, the plurality of cells comprises one or more microorganisms. In some embodiments, the plurality of cells are dormant and / or viable cells. In some embodiments, the plurality of cells are different cell species, or are the same cell species. In some embodiments, the plurality of cells comprises one or more microbial cells, one or more microbial spores, one or more microorganisms, or any combination thereof.

[0153] In some embodiments, the polymeric fiber comprises a solid porous shell and a solid or semi-solid core. In some embodiments, the polymeric fiber comprising a plurality of cells has a cylindrical structure. In some embodiments, the core of the cylindrical structure polymeric fiber comprises less than 90%, less than 80%, less than 70%, less than 60%, less than 50%, less than 40%, less than 30%, less than 20%, less than 10%, less than 5% or between 5% and 50%, between 10% and 90%, between 5% and 50%, between 10% and 70%, between 10% and 30% of the void relative to the entire volume of the core, including any range between the two. In some embodiments, the polymeric fiber comprising or encapsulating a plurality of cells is referred to herein as the polymeric fiber of the present invention.

[0154] In some embodiments, the polymeric fibers of the present invention are characterized by an average cross-section of between 1 and 500 um, between 1 and 10 um, between 10 and 100 um, between 10 and 50 um, between 50 and 100 um, between 50 and 300 um, between 50 and 400 um, between 50 and 500 um, between 10 and 500 um, between 10 and 300 um, between 100 and 500 um, between 10 and 300 um, between 100 and 500 um, between 10 and 300 um, between 10 and 400 um, between 10 and 150 um, between 10 and 200 um, between 10 and 350 um, between 100 and 300 um, between 300 and 500 um, including any ranges therebetween.

[0155] In some embodiments, the polymeric fibers of the present invention are characterized by an average cross-section of between 10 and 500 um, between 10 and 100 um, between 10 and 200 um, between 10 and 150 um, between 10 and 300 um, including any ranges therebetween, wherein the porous shell of the polymeric fiber is a porous solid shell consisting essentially of a water-insoluble polymer and optionally a water-soluble polymer (as disclosed below); the hydrophilic core of the polymeric fiber consists essentially of a plurality of cells and a water-soluble material; and wherein the water-soluble material in the core of the polymeric fiber consists essentially of a water-soluble polymer and one or more sugars.

[0156] In some embodiments, the polymeric fibers of the present invention are characterized by an average cross-section of between 10 and 500 um, between 10 and 100 um, between 10 and 200 um, between 10 and 150 um, between 10 and 300 um, including any ranges therebetween, wherein the porous shell of the polymeric fiber is a porous solid shell that is mainly composed of a water-insoluble polymer (e.g., cellulose, a water-insoluble cellulose derivative, or PVDF-HFP) and optionally a water-soluble polymer (as disclosed below); the hydrophilic core of the polymeric fiber is mainly composed of a plurality of cells and a water-soluble material, the water-soluble material being mainly composed of sugars and water-soluble polymers disclosed herein (e.g., water-soluble gums, polyalkylene oxides, etc.); and wherein the water-soluble material in the core of the polymeric fiber is mainly composed of a water-soluble polymer and one or more sugars.

[0157] In some embodiments, the w / w concentration of the water-soluble polymer within the polymeric fibers or fibrous materials of the present invention is between 0.1% and 20%, between 0.5% and 20%, between 0.5% and 15%, between 0.5% and 10%, between 1% and 20%, between 1% and 15%, between 1% and 10%, between 1% and 5%, between 5% and 20%, between 5% and 15%, including any ranges therebetween.

[0158] In some embodiments, the w / w concentration of the water-insoluble polymer within the polymeric fibers or fibrous materials of the present invention is between 2% and 30%, between 5% and 30%, between 10% and 30%, between 10% and 20%, between 2% and 20%, between 5% and 15%, between 5% and 10%, between 5% and 20%, including any ranges therebetween.

[0159] In some embodiments, the polymeric fibers are characterized by an average length of from about 0.1 millimeter (mm) to about 20 centimeters (cm) or longer, such as from about 1-20 cm, such as from about 5-10 cm, between 0.1 and 200 mm, between 0.1 and 1 mm, between 1 and 10 mm, between 10 and 50 mm, between 50 and 100 mm, between 10 and 200 mm, between 50 and 200 mm, between 100 and 200 mm, including any ranges therebetween.

[0160] In some embodiments, the polymeric fibers are characterized by an average aspect ratio (e.g., the ratio between the length and cross-section of the polymeric fibers) of at least 10, at least 100, at least 1000, at least 10,000, at least 50,000, including any ranges therebetween.

[0161] In some embodiments, polymeric fibers are characterized by an average aspect ratio (eg, the ratio of the length to the cross-section of the polymeric fibers) that is representative of a theoretical 2D structure.

[0162] In some embodiments, the porous shell of the polymeric fiber includes a plurality of holes. In some embodiments, the pore size and pore density (or porosity) of the polymeric fiber per surface unit are sufficient to maintain the viability of the cells encapsulated in the polymeric fiber. In some embodiments, the pore size and pore density (or porosity) of the polymeric fiber per surface unit are sufficient to support the activation of the cells encapsulated in the polymeric fiber when the polymeric fiber is in contact with the activation solution. In some embodiments, the pore size sufficient to support activation is a pore size that can support the mass transfer of cell nutrients (such as from the surrounding environment to the core, and / or from the core to the surrounding environment), sufficient to induce and / or maintain cell activity (e.g., substantially biological activity, such as cell metabolism). As used herein, the term "mass transfer" refers to the net movement of a liquid composition containing cell nutrients dissolved or dispersed therein, wherein the net movement is from the environmental solution to the core of the polymeric fiber, or from the core of the polymeric fiber to the environmental solution. In some embodiments, the viability of the cell determines the shelf life of the product of the present invention. In some embodiments, if at least 50%, at least 60%, at least 70%, between 50% and 100%, between 50% and 90%, between 70% and 100%, between 70% and 95% of the initial cell load is viable (cell load is defined as the number of CFU per gram of preparation, or per cm 2 In some embodiments, the activation is supported to obtain at least 50%, at least 60%, at least 70%, between 50% and 100%, between 50% and 90%, between 70% and 100%, between 70% and 95% of the initial cell load being activated, including any ranges therebetween.

[0163] In some embodiments, the porosity sufficient to support activation of cells encapsulated within the polymeric fibers is at least 50%, at least 60%, at least 70%, between about 60% and 90%, between about 70% and about 90%, between about 70% and about 95%, including any ranges therebetween. As used herein, the term "porosity" refers to an average value of a composition comprising a plurality of polymeric fibers. Porosity can be determined based on microscopic images of the fibers (e.g., obtained by SEM).

[0164] In some embodiments, the pores within the porous shell of the polymeric fiber are characterized by an average pore size of between 10 and 500 nm, between 10 and 300 nm, between 100 and 500 nm, between 20 and 80 nm, between 80 and 120 nm, between 50 and 200 nm, between 80 and 200 nm, between 150 and 200 nm, between 50 and 500 nm, including any ranges therebetween.

[0165] In some embodiments, the polymeric fibers of the present invention are characterized by: (i) an average pore size between 30 and 300 nm, between 30 and 400 nm, between 30 and 500 nm, between 40 and 400 nm, between 40 and 300 nm, between 50 and 300 nm, between 50 and 400 nm, between 50 and 500 nm, between about 50 and about 300 nm, including any ranges therebetween; and (ii) a porosity of at least 50%, at least 60%, at least 70%, between about 60% and 90%, between about 70% and about 90%, between about 70% and about 95%, including any ranges therebetween. In some embodiments, the polymeric fibers of the present invention suitable for supporting activation of cells encapsulated therein are characterized by an average pore size between about 50 and about 300 nm; and a porosity of at least about 70%.

[0166] In some embodiments, the polymeric fiber is characterized by a plurality of pores, as described above, and further characterized by openings (e.g., cutouts) having an average size range of between 1 and 10 um, between 0.5 and 10 um, between 1 and 100 um, between 1 and 2 um, between 1 and 10 um, between 1 and 2 um, between 2 and 5 um, between 5 and 10 um, including any ranges therebetween. One skilled in the art will appreciate that the average pore size is calculated based on an SEM micrograph of the substrate.

[0167] In some embodiments, the polymeric fibers are characterized by an average pore size of about 1 micrometer.

[0168] In some embodiments, the shell of the polymeric fiber is a hydrophobic shell comprising a water-insoluble polymer. In some embodiments, the water-insoluble polymer is characterized by a water solubility of at most 0.5 g / L, at most 0.1 g / L, at most 0.05 g / L, at most 0.01 g / L, at most 0.005 g / L, at most 0.001 g / L, or less, including any ranges therebetween.

[0169] In some embodiments, the water-insoluble polymer is characterized by a solubility in a water-immiscible organic solvent of at least 5 g / L, at least 10 g / L, at least 20 g / L, at least 50 g / L, at least 100 g / L, including any ranges therebetween. In some embodiments, the water-insoluble polymer is a water-dispersible polymer.

[0170] In some embodiments, the water-insoluble polymer is characterized by a solubility in a water-miscible or water-immiscible organic solvent of at least 5 g / L, at least 10 g / L, at least 20 g / L, at least 50 g / L, at least 100 g / L (e.g., when measured at a temperature between 10 and 30° C., between 10 and 50° C., or between 0 and 90° C.). In some embodiments, the water-insoluble polymer is characterized by a solubility in a solvent selected from THF, DMF, acetone, DMAC, chloroform, DMSO, DCM, NMP, TCE, TFE, butanol, methanol, ethanol, HFP, isopropanol, ethyl acetate, ethanolamine, pentane, ethylene glycol, diethyl ether, butyronitrile, acetonitrile, chlorobenzene (including any combination thereof) of at least 5 g / L, at least 10 g / L, at least 20 g / L, at least 50 g / L, at least 100 g / L.

[0171] In some embodiments, the water-insoluble polymer comprises a fluoropolymer, including any copolymer thereof. In some embodiments, the hydrophobic polymer is or comprises PVDF-HFP (poly(vinylidene fluoride-hexafluoropropylene)). In some embodiments, the water-insoluble polymer comprises or consists essentially of cellulose and / or a water-insoluble cellulose derivative.

[0172] In some embodiments, the water-insoluble polymer is selected from cellulose, fluorinated polymers (such as PVDF-HFP), PVP, PCL, PLA, PGA, polystyrene, PES, acrylate polymers, water-insoluble polysaccharides, water-insoluble cellulose derivatives, including any combination and any copolymer thereof. In some embodiments, water-insoluble cellulose derivatives include, but are not limited to: carboxyalkylated cellulose (such as carboxymethyl cellulose or CMC, hydroxypropyl methyl cellulose), alkylated cellulose (methyl cellulose, ethyl cellulose, ethyl methyl cellulose), hydroxyalkylated cellulose (such as hydroxyethyl cellulose, hydroxypropyl cellulose), alkoxylated cellulose, acylated cellulose (such as cellulose acetate, cellulose acetate phthalate), including any combination and any copolymer thereof.

[0173] In some embodiments, the shell comprises up to 90%, up to 88%, up to 87%, up to 86% w / w of the shell on a dry weight basis of water-insoluble polymer. In some embodiments, the shell comprises between 50% and 90%, between 50% and 80%, between 70% and 90%, between 60% and 70%, between 70% and 86%, between 60% and 86%, between 80% and 90%, between 80% and 85%, between 80% and 88%, between 80% and 86%, between 80% and 83%, between 83% and 90%, between 83% and 86%, between 85% and 88% of the water-insoluble polymer, including any ranges therebetween.

[0174] In some embodiments, the shell further comprises a water-soluble polymer of up to 20%, up to 15%, up to 13%, up to 10%, up to 8%, up to 5% or between 5% and 20%, between 5% and 15%, including any range therebetween. In some embodiments, the water-soluble polymer is as described above. In some embodiments, the water-soluble polymer is or includes PVP or a polyether (e.g., polyalkylene oxide, such as polyethylene glycol (PEG), polypropylene glycol (PPG)). In some embodiments, the shell includes or is mainly composed of a mixture of PVDF-HFP (as a hydrophobic polymer) and PVP (as a water-soluble polymer), wherein the w / w concentration of each of PVDF-HFP and PVP is as described herein.

[0175] In some embodiments, the average molecular weight of the water-insoluble polymer is between 100.000 and 2.000.000 Da, between 100.000 and 1.000.000 Da, between 100.000 and 300.000 Da, between 300.000 and 500.000 Da, between 100.000 and 500.000 Da, between 200.000 and 800.000 Da, between 300.000 and 500.000 Da, between 200.000 and 800.000 Da, between 300.000 and 500.000 Da. Between 800.000 Da, between 500.000 and 800.000 Da, between 1.000.000 and 2.000.000 Da, between 1.000.000 and 1.500.000 Da, between 1.500.000 and 2.000.000 Da, between 500.000 and 800.000 Da, between 500.000 and 800.000 Da, including any ranges therebetween.

[0176] In some embodiments, the average molecular weight of PVDF-HFP is between 100.000 and 800.000 Da, between 100.000 and 300.000 Da, between 300.000 and 500.000 Da, between 100.000 and 500.000 Da, between 200.000 and 800.000 Da, between 300.000 and 800.000 Da, between 500.000 and 800.000 Da, including any ranges therebetween.

[0177] In some embodiments, the average molecular weight of PVP is between 500.000 and 2.000.000 Da, between 500.000 and 1.000.000 Da, between 1.000.000 and 2.000.000 Da, between 1.000.000 and 1.500.000 Da, between 1.500.000 and 2.000.000 Da, between 500.000 and 800.000 Da, between 500.000 and 800.000 Da, including any ranges therebetween.

[0178] In some embodiments, the term "average molecular weight" refers to the weight average molecular weight (Mw), which is well known in the art. In some embodiments, the term "average molecular weight" refers to the number average molecular weight (Mn). In some embodiments, the term "Mn" generally refers to a molecular weight measurement calculated by dividing the total weight of all polymer molecules in a sample by the total number of polymer molecules in the sample.

[0179] In some embodiments, the shell is characterized by a thickness between 10nm and 10um, between 50 and 500nm, between 50nm and 1um, between 50nm and 10um, between 50 and 100nm, between 100 and 200nm, between 100 and 500nm, between 100 and 1000nm, between 500 and 700nm, between 500 and 1000nm, between 100nm and 5um, between 100nm and 1um, between 100nm and 10um, including any ranges in between.

[0180] In some embodiments, the shell further comprises trace amounts of water or a water-immiscible organic solvent, or either of the two.

[0181] In some embodiments, the w / w ratio of the polymeric fiber inner shell to the core is between 50:1 and 1:50, between 5:1 and 1:50, between 1:1 and 1:50, between 1:5 and 1:50, between 1:5 and 1:10, between 1:10 and 1:50, between 1:10 and 1:20, between 1:10 and 1:30, between 1:20 and 1:50, between 1:30 and 1:50, including any ranges therebetween.

[0182] In some embodiments, the core is in a solid or semi-solid state. In some embodiments, the core stably encapsulates cells. In some embodiments, cells are stably encapsulated in the core. In some embodiments, cells are stably bound to the core component or are stably encapsulated in the core component. In some embodiments, the core is substantially free of pores. In some embodiments, the core is substantially impermeable to water vapor and / or gas. In some embodiments, the core includes a large amount of filler. In some embodiments, the core includes one or more materials that can expand during electrospinning, thereby providing mechanical support for the entire polymeric fiber. In some embodiments, the core can provide or enhance the mechanical stability of the fiber. In some embodiments, the core is in the form of a gel or glassy material.

[0183] In some embodiments, the core is in a glassy state at a temperature between 10 and 30°C, between 10 and 40°C, between 10 and 50°C, between 10 and 60°C, or higher, including any range in between. In some embodiments, the core comprises a plurality of cells, a sugar, and a water-soluble polymer. In some embodiments, the plurality of cells constitute up to 90%, up to 80%, up to 70%, up to 60%, up to 50%, up to 30% of the core, including any range in between, by dry weight. In some embodiments, the plurality of cells constitute up to 90%, up to 80%, up to 70%, up to 60%, up to 50%, up to 30%, up to 20% of the polymeric fiber of the present invention, by dry weight.

[0184] In some embodiments, the water-soluble polymer is characterized by a water solubility of at least 1 g / L, at least 5 g / L, at least 10 g / L, at least 20 g / L, at least 50 g / L, at least 100 g / L, including any ranges therebetween. In some embodiments, the water-soluble polymer is characterized by a solubility in an aqueous solvent (such as an aqueous buffer, saline, or water; measured at a temperature between 10 and 30° C., between 10 and 50° C., or between 0 and 90° C.) of at least 5 g / L, at least 10 g / L, at least 20 g / L, at least 50 g / L, at least 100 g / L.

[0185] In some embodiments, the water-soluble polymer comprises a single polymer species. In some embodiments, the water-soluble polymer comprises a plurality of different polymers. In some embodiments, the water-soluble polymer is or comprises a water-soluble polysaccharide. In some embodiments, the water-soluble polysaccharide is a water-soluble gum. In some embodiments, the water-soluble gum is or comprises carrageenan (such as λ-carrageenan). In some embodiments, the water-soluble polysaccharide is or comprises carrageenan (such as λ-carrageenan). In some embodiments, the water-soluble polymer is mainly composed of water-soluble gum.

[0186] In some embodiments, the water-soluble polymer and / or sugar is substantially non-hygroscopic. In some embodiments, the water-soluble polymer and / or sugar is characterized in that the hygroscopicity is significantly lower than that of glycerol. In some embodiments, the water-soluble material disclosed herein is characterized in that its hygroscopicity is significantly lower than that of glycerol (e.g., 1.5, 2, 3, 5, or 10 times lower hygroscopicity, including any ranges therebetween).

[0187] In some embodiments, the sugar includes one or more of disaccharides, monosaccharides, oligosaccharides, or any combination thereof.

[0188] Non-limiting examples of disaccharides and monosaccharides include, but are not limited to, D-sugars and / or L-sugars, such as sucrose, maltose, fructose, glucose, galactose, isomaltulose, trehalose, psicose, tagatose, and sorbitol, including any combination thereof.

[0189] In some embodiments, the sugars include a first sugar (such as sucrose) and a second sugar (such as maltose). In some embodiments, the w / w ratio of the first sugar and the second sugar in the core (and / or in the fiber) is between 1:1 and 20:1, between 1:1 and 5:1, between 5:1 and 10:1, between 10:1 and 15:1, between 15:1 and 20:1, including any ranges therebetween.

[0190] In some embodiments, the sugar weight content in the core is at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% w / w of the core dry weight, including any ranges therebetween. In some embodiments, the sugar weight content in the fiber is at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% w / w of the fiber dry weight, including any ranges therebetween.

[0191] In some embodiments, the water-soluble polymer constitutes up to 20%, up to 15%, up to 10%, up to 5%, up to 3%, up to 2%, up to 1%, up to 0.5% of the core, including any ranges in between, by dry weight. In some embodiments, the water-soluble polymer constitutes up to 10%, up to 7%, up to 5%, up to 3%, up to 2%, up to 1%, up to 0.5% of the core, including any ranges in between, by dry weight. In some embodiments, the water-soluble polymer constitutes up to 5%, up to 3%, up to 2%, up to 1%, up to 0.5% of the core, including any ranges in between, by dry weight. In some embodiments, the water-soluble polymer constitutes at least 0.1%, at least 0.3%, at least 0.5%, at least 0.7%, at least 1%, at least 2%, including any ranges in between, by dry weight of the core.

[0192] In some embodiments, the water-soluble polymer is or includes λ-carrageenan. In some embodiments, the water-soluble polymer is mainly composed of λ-carrageenan. The inventors were surprised to find that λ-carrageenan is a preferred material for obtaining polymeric fibers that stably encapsulate dormant cells, wherein the dormant cells maintain their viability for an extended period of at least 3 months or at least 6 months. Therefore, it has been surprisingly found that the mat of the present invention comprising a water-soluble polymer with sucrose and maltose as sugars and λ-carrageenan as a core is characterized by an extended shelf life (such as at least 1 month, at least 3 months, at least 6 months, at least 9 months, at least 12 months or longer) when stored under conventional storage conditions as described herein.

[0193] In some embodiments, the core further comprises an active ingredient (eg, a pharmaceutically active agent, a cosmeceutical active agent, a nutraceutical, a cell-nutrient ingredient, or any combination thereof).

[0194] In some embodiments, the polymeric fibers include between 40% and 98%, between 50% and 98%, between 70% and 98%, between 60% and 98%, between 70% and 95%, between 60% and 95%, between 80% and 95%, between 40% and 90%, between 50% and 90%, between 80% and 95%, between 80% and 98% of the plurality of cells and / or plurality of spores of the polymeric fibers on a dry weight / weight (w / w) basis, including any ranges therebetween.

[0195] In some embodiments, the polymeric fibers of the present invention are electrospun microfibers; wherein at least 85%, at least 90%, at least 95%, at least 99%, or between 85% and 95%, between 85% and 100%, between 90% and 10%, between 95% and 99% of the dry weight of the polymeric fibers of the present invention consists of water-soluble material and a plurality of cells, forming a hydrophilic core encapsulated by a porous hydrophobic shell; wherein the porous hydrophobic shell consists primarily of a water-insoluble polymer and, optionally, a water-soluble polymer; and wherein the water-soluble material consists primarily of a water-soluble polymer and a sugar; and wherein the water-soluble polymer, the water-insoluble polymer, and the sugar are as described above.

[0196] In some embodiments, at least 85%, at least 90%, at least 95%, at least 99%, or between 85% and 95%, between 85% and 100%, between 90% and 10%, between 95% and 99% of the dry weight of the polymeric fiber of the present invention consists of: (i) one or more water-soluble polymers, such as PEG and / or water-soluble gums; (ii) one or more sugars; (iii) a water-insoluble polymer, such as cellulose or a water-insoluble cellulose derivative, and optionally, a water-soluble polymer; and (iv) a plurality of cells encapsulated within the polymeric fiber; wherein (i) and (ii) form the core of the water-soluble material, and wherein (iii) forms the porous shell of the polymeric fiber.

[0197] Fiber Materials

[0198] In one aspect of the invention, a fibrous material comprising electrospun fibers disclosed herein is provided, wherein each electrospun fiber comprises a hydrophobic shell as disclosed herein and a hydrophilic core comprising a water-soluble material and a plurality of cells as disclosed herein. In some embodiments, the hydrophilic core is in the form of a hollow tube. In some embodiments, the electrospun fibers of the fibrous material are substantially free of dead cells. In some embodiments, the fibrous material is a dry fibrous material characterized in that the water content is less than 10%, less than 5%, less than 3%, less than 1%, less than 0.5%, less than 0.1%, less than 0.05%, less than 0.01%, including any ranges therebetween. In some embodiments, the fibrous material is a dry mat.

[0199] In another aspect of the present invention, there is provided herein a fibrous material comprising the polymeric fiber of the present invention, wherein the polymeric fiber comprises a plurality of cells, one or more microorganisms and / or spores encapsulated therein, wherein the cells or spores are dormant and / or viable. In some embodiments, the fibrous material is in the form of a fiber mat comprising one or more nonwoven uniform layers or matrices.

[0200] In some embodiments, the fibrous material is a porous matrix characterized by an average porosity of about 10%, 20%, about 50%, about 70%, about 90%, between 50 and 99%, between 60 and 90%, or more, including any ranges therebetween.

[0201] In some embodiments, the fiber material is characterized by an average pore size ranging between 10 and 400um, between 10 and 50um, between 50 and 80um, between 80 and 100um, between 100 and 150um, between 150 and 200um, between 150 and 300um, between 100 and 400um, between 150 and 400um, between 200 and 400um, or greater than 100um, including any range therebetween. In some embodiments, the fiber material is characterized by an average pore size of 1 micron or greater. In some embodiments, the fiber material is characterized by an average pore size of less than 10um. In some embodiments, the pore size of the fiber material refers to the spaces between polymeric fibers in the matrix.

[0202] Those skilled in the art will appreciate that the average pore size can be calculated based on SEM micrographs of the matrix.

[0203] In some embodiments, the fibrous material is characterized by an average thickness between 10 and 10000um, between 10 and 2000um, between 10 and 50um, between 50 and 100um, between 100 and 200um, between 100 and 500um, between 500 and 1000um, between 100 and 2000um, between 200 and 2000um, between 500 and 2000um, between 1000 and 2000um, between 2000 and 10000um, between 2000 and 5000um, between 2000 and 7000um, including any ranges therebetween.

[0204] In some embodiments, the fibrous material is substantially dry. In some embodiments, the mat is substantially free of moisture. In some embodiments, the mat is wet. In some embodiments, the fibrous material is moist. In some embodiments, the mat has a moisture content of less than 10%, less than 5%, less than 3%, less than 1%, less than 0.5%, less than 0.1%, less than 0.05%, less than 0.01%, including any range therebetween. In some embodiments, the fibrous material of the present invention contains trace amounts of water and / or organic solvents.

[0205] In some embodiments, the fibrous material in a dry state of the present invention is characterized by an extended shelf life when stored under appropriate storage conditions as described herein. In some embodiments, shelf life refers to the ability of the fibrous material to substantially maintain the viability of dormant cells, as described herein. In some embodiments, the viability of dormant cells is the ability of cells to proliferate and / or secrete metabolites. In some embodiments, the fibrous material includes live active (non-dormant) cells. In some embodiments, the fibrous material includes a plurality of live active (non-dormant) cells. In some embodiments, the fibrous material is substantially free of dead cells (e.g., dead cells do not exceed 30%, 20%, or 10% relative to the total number of cells in the fibrous material).

[0206] In some embodiments, the fibrous material comprises a plurality of dormant cells encapsulated with a core of polymeric fibers. In some embodiments, the dry weight / weight (w / w) concentration of the encapsulated dormant cells in the mat is at most 98%, at most 95%, at most 93%, at most 90%, at most 80%, at most 70%, at most 60%, at most 50%, at most 40%, relative to the dry weight of the fibrous material. It will be appreciated by those skilled in the art that the cell loading in the fibrous material may vary and is predetermined by the desired properties of the fibrous material. Generally, it is desirable that the material have the highest possible loading of encapsulated cells / spores and / or microorganisms.

[0207] In some embodiments, the dry weight / weight (w / w) concentration of cells in the fiber material is between about 10% and about 98%, between about 10% and about 95%, between about 10% and about 93%, between about 10% and about 90%, between about 10% and about 80%, between 10% and 30%, between 20% and 30%, between 30% and 40%, between 30% and 80%, between 30% and 50%, between 50% and 80%, between 40% and 80%, between 40% and 60%, between 60% and 80%, including any ranges therebetween.

[0208] In some embodiments, the fibrous materials of the present invention are characterized by a cell loading (e.g., active cell CFU per area or volume of the mat) sufficient to secrete a cosmeceutical effective amount of a metabolite (or a cosmeceutical active ingredient). In some embodiments, the mats of the present invention are characterized by a cell loading sufficient to replenish an effective amount of a metabolite to the skin of a subject (e.g., when dormant cells are activated using an activation solution as described herein).

[0209] In some embodiments, the cell loading is at least 10E3 CFU / cm 2 , at least 10E5 CFU / cm 2 , at least 10E7 CFU / cm 2 , at least 10E10 CFU / cm 2, at least 10E13 CFU / cm 2 , 10E5 and 10E15 CFU / cm 2 Between 10E7 and 10E15 CFU / cm 2 Between 10E10 and 10E15 CFU / cm 2 Between 10E6 and 10E15 CFU / cm 2 Between 10E8 and 10E15 CFU / cm 2 Between 10E5 and 10E13 CFU / cm 2 Between 10E10 and 10E13 CFU / cm 2 between, including any range between.

[0210] The term "cell" as used herein refers to a eukaryotic or prokaryotic cell.

[0211] According to some embodiments of the invention, the cell comprises a cell wall. Non-limiting examples of cells that comprise a cell wall and can be encapsulated in the polymeric fibers of the invention include plant cells, bacteria (such as Gram-positive and Gram-negative bacteria), archaea, protozoa, fungi, yeast, and algae, including any spores thereof and / or any combination thereof.

[0212] According to some embodiments of the present invention, the cell includes a cosmeceutical acceptable cell (e.g., a cosmeceutical pure bacteria and / or a bacteria approved for cosmeceutical use). In some embodiments, the cell includes a probiotic. In some embodiments, the cell includes a single bacterial species. In some embodiments, the cell includes a plurality of bacterial species. In some embodiments, the cell includes a microbial cell, a microbial spore, or both. In some embodiments, the cell is or includes a plant cell. In some embodiments, the cell is or includes an animal cell (e.g., a mammalian cell). In some embodiments, the cell includes a Lactobacillus (Lactiplantibacillus) genus bacterium, including any subspecies thereof. In some embodiments, the cell includes a Lactobacillus plantarum (Lactiplantibacillus plantarum). In some embodiments, the cell includes a Lactobacillus bacterium, including any subspecies thereof.

[0213] In some embodiments, the cell comprises a microorganism capable of secreting a metabolite (e.g., wherein the cell is in an activated state). In some embodiments, the metabolite is a cosmeceutical active ingredient. In some embodiments, the cell is or comprises a dormant cell, wherein the dormant cell is a probiotic microorganism and / or spore thereof, which is capable of secreting a metabolite upon activation thereof (e.g., by exposing the cell to an activation composition disclosed herein).

[0214] In some embodiments, the cells are isolated cells (e.g., purified from growth media, debris, nutrients, etc.). In some embodiments, the cells are isolated bacteria. In some embodiments, the cells are free of human pathogens and / or toxins. In some embodiments, the cells are characterized by a purity (e.g., cell culture purity) of at least 90%, at least 95%, at least 97%, at least 99%, at least 99.9%, at least 99.99%, including any ranges therebetween.

[0215] In some embodiments, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% of the total number of cells (e.g., CFU) in the mat are encapsulated or located within the core of the polymeric fiber. Without being bound by any particular theory, it is hypothesized that the dormant cells are primarily encapsulated within the fiber, such that only a small portion (e.g., at most 30%, at most 20%, at most 10%, at most 5%, including any ranges therebetween) of the dormant cells are optionally located outside the core of the fiber.

[0216] In some embodiments, upon wetting the mat with a liquid (e.g., an activation solution), at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% of the total number of cells (e.g., CFU) within the mat remain encapsulated or located within the core of the polymeric fibers. Without being bound by any particular theory, it is hypothesized that upon wetting of the mat, metabolites are free to diffuse into the liquid (located on the exterior of the wet mat), while encapsulated bacteria remain substantially within the core of the fibers. It should further be apparent that due to the mass transfer enabled by the porous fiber shell, at least a portion of the metabolites can reach the subject's skin.

[0217] In some embodiments, the cells encapsulated in the polymeric fibers are substantially viable. In some embodiments, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99%, at least 99.9% of the cells encapsulated in the polymeric fibers are viable. In some embodiments, as used herein, the term "viable" includes the ability to: replicate genome or DNA, cell proliferation or replication, RNA synthesis, protein translation, fermentation or any equivalent energy production process, secrete active compounds (such as metabolites or cell metabolites, as disclosed herein), or any combination thereof. In some embodiments, as used herein, the term "viable" refers to cells being in an active state. In some embodiments, the term "viable" further includes the ability of cells to transition from a dormant state to an active state, such as when they are in contact with an activation composition as disclosed herein. In some embodiments, transitioning from a dormant state to an active state also refers to the activation of dormant cells herein.

[0218] In some embodiments, the cells encapsulated in the polymeric fibers are in a dormant state. In some embodiments, the cells encapsulated in the polymeric fibers are capable of transitioning from a dormant state to an active state. In some embodiments, the cells in an active state are capable of performing any cellular biochemical process known in the art. In some embodiments, the cells in an active state are capable of: replicating genomes or DNA, cell proliferation or replication, RNA synthesis, protein translation, fermentation, or any equivalent energy production process. In some embodiments, the cells in an active state are capable of synthesizing and / or secreting active compounds (e.g., metabolites, such as cosmeceutical active ingredients). In some embodiments, the cells in an active state are characterized by synthesizing and secreting active compounds. It will be appreciated by those skilled in the art that cell viability can be determined and / or monitored by analyzing the concentration of one or more metabolites in the growth medium. In a non-limiting exemplary embodiment, as described herein, the viability of cells (of the genus Lactobacillus, such as Lactobacillus plantarum) is determined herein by measuring the lactate concentration in the activation composition when the activation composition is in contact with the dry mat of the present invention under appropriate conditions.

[0219] In some embodiments, the w / w concentration of the water-soluble polymer in the fibrous material of the present invention is between 0.1% and 20%, between 0.5% and 20%, between 0.5% and 15%, between 0.5% and 10%, between 1% and 20%, between 1% and 15%, between 1% and 10%, between 1% and 5%, between 5% and 20%, between 5% and 15%, including any ranges therebetween.

[0220] In some embodiments, the w / w concentration of the water-insoluble polymer in the fiber material of the present invention is between 2% and 30%, between 5% and 30%, between 10% and 30%, between 10% and 20%, between 2% and 20%, between 5% and 15%, between 5% and 10%, between 5% and 20%, including any ranges therebetween. In some embodiments, the w / w concentration of the water-soluble polymer in the fiber material of the present invention is between about 0.5% and about 10%, and the w / w concentration of the water-insoluble polymer in the fiber material of the present invention is between 5% and 20%, including any ranges therebetween.

[0221] In some embodiments, the fiber material of the present invention is a formable fiber material (as described below), wherein the formable fiber material is mainly composed of the polymeric fibers of the present invention (i.e., the electrospun polymeric fibers disclosed herein), and is characterized by: (i) a dry weight / weight (w / w) concentration of encapsulated cells ranging from about 10% to about 95%, about 10% to about 93%, about 10% to about 90%, about 10% to about 80%, including any ranges therebetween; (ii) a thickness between 10 um and about 2000 um, or between 10 um and about 1500 um; and (iii) an average fiber diameter between about 10 um and about 300 um, or between about 10 um and about 200 um.

[0222] In some embodiments, at least 85%, at least 90%, at least 95%, at least 99%, or between 85% and 95%, between 85% and 100%, between 90% and 10%, between 95% and 99% of the dry weight of the formable fibrous material of the present invention consists of the polymeric fibers of the present invention. In some embodiments, the formable fibrous material of the present invention is further characterized by a water absorption capacity of up to 1000% or up to about 700%, relative to the dry weight of the material, and a tensile strength of at least 1 MPa, at least 2 MPa, at least 5 MPa, at least 7 MPa, at least 10 MPa, 2 to 100 MPa, 2 to 50 MPa, 2 to 10 MPa, 2 to 20 MPa, including any ranges therebetween.

[0223] In some embodiments, the fibrous material further comprises an edible substance. In some embodiments, the mat further comprises a plant material. In some embodiments, the mat further comprises a plant extract. In some embodiments, the plant material is or comprises a cosmeceutical active ingredient. In some embodiments, the mat further comprises a metabolite (e.g., a cellular metabolite, a plant metabolite, a bacterial metabolite, a fungal metabolite, or any combination thereof). In some embodiments, the fibrous material is primarily composed of a biocompatible material or a cosmeceutical grade material. In some embodiments, the core of the polymeric fiber mat is primarily composed of a biocompatible material or a cosmeceutical grade material. In some embodiments, the core of the polymeric fiber mat is primarily composed of a natural or naturally derived compound or ingredient.

[0224] In some embodiments, the fibrous materials of the present invention are characterized by a pleasant tactile feel when applied to the skin of a subject.

[0225] In some embodiments, the fibrous materials of the present invention are characterized by a water absorption capacity of between 50% and 5000%, between 50% and about 1000%, between 50% and 800%, between 50% and 700%, between about 50% and 100%, between 100% and 5000%, between 100% and 500%, between 500% and 1000%, between 1000% and 5000%, between 1000% and 3000%, 800%, up to 700%, up to 600%, between 3000% and 5000%, including any ranges therebetween. In some embodiments, the fibrous materials of the present invention are characterized by a water absorption capacity of between 50% and about 1000%, between 50% and 800%, between 50% and 700%, between about 50% and 500%, including any ranges therebetween. In some embodiments, the water absorption is relative to the dry weight of the mat.

[0226] In some embodiments, the fibrous material is in the form of a cosmeceutical product, a cosmetic product, or a cosmetic preparation. In some embodiments, the fibrous material in the form of a cosmetic / cosmeceutical product or a cosmetic / cosmeceutical preparation is an elastic fibrous material. In some embodiments, the fibrous material in the form of a cosmetic / cosmeceutical product or a cosmetic / cosmeceutical preparation is a formable fibrous material.

[0227] In some embodiments, the formable fibrous material comprises a flexible, elastic and / or deformable material capable of acquiring a predetermined shape. In some embodiments, the formable fibrous material in a wet state is configured to acquire a predetermined shape and maintain its shape for a predetermined period of time (e.g., 1 minute to 10 hours). In some embodiments, the formable fibrous material in a wet state is characterized by capillary adhesion to the application site. In some embodiments, the predetermined shape is substantially the shape of the application site (e.g., an area within the subject's skin, such as the face, palm, foot, etc.). In some embodiments, the formable fibrous material in a wet state is configured to bind to the application site by substantially acquiring the shape of the application site, wherein the binding time is a predetermined period of time as described above.

[0228] In some embodiments, the formable fibrous material is characterized by elasticity sufficient to apply it to the target site. In some embodiments, the formable fibrous material is characterized by elasticity sufficient to substantially obtain the shape of the application site, where substantially refers to at least 80%, at least 90%, at least 95% similarity in shape, including any ranges in between. In some embodiments, the cosmetic is a ski mask (e.g., a face mask) comprising or consisting mainly of the formable fibrous material disclosed herein. In some embodiments, the width and length dimensions of the cosmetic are compatible with the size of the application site. In some embodiments, the width and length dimensions of the cosmetic are sufficient to cover at least 70%, at least 80%, at least 85%, at least 90%, at least 95%, at least 99% of the target site. In some embodiments, the target site refers to the application site on the subject's skin. In some embodiments, the target site includes any site on the human body. In some embodiments, the width and length dimensions of the cosmetic are compatible with the size of the application site, and further the thickness is between 10 and about 2000um.

[0229] In some embodiments, the cosmetic is in the form of a uniform layer or sheet. In some embodiments, the cosmetic has at least one dimension (length and / or width) ranging from 1 to 50 cm, 1 to 10 cm, 5 to 10 cm, 1 to 30 cm, 1 to 20 cm, 10 to 50 cm, 10 to 20 cm, 20 to 50 cm, 30 to 50 cm, including any ranges therebetween.

[0230] In some embodiments, the cosmetic comprises a damp pad of the present invention. In some embodiments, the cosmetic comprises a pad of the present invention soaked or moistened with an activating composition. In some embodiments, the damp pad has sufficient moisture to (i) activate dormant cells. In some embodiments, the damp pad has sufficient moisture to (ii) support free diffusion of the cosmeceutical active from the core to the exterior of the cosmeceutical, where the exterior is in contact with the skin (target site). In some embodiments, the damp pad has sufficient moisture to replenish the skin with an effective amount of the cosmeceutical active. In some embodiments, the damp pad has sufficient moisture to induce sufficient capillary forces to stably adhere the damp pad to the skin (target site) of the subject.

[0231] In some embodiments, a cosmetic comprising or consisting essentially of a moist pad, comprising cells encapsulated therein in an active state, is referred to herein as a ready-to-use cosmeceutical. In some embodiments, upon contacting the dry pad with an activating composition under appropriate conditions, as described herein, the dormant cells are activated. In some embodiments, the ready-to-use cosmetic comprises at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, at least 97%, at least 99% activated cells, wherein the percentage of activated cells is relative to the amount of dormant cells in the dry pad of the present invention.

[0232] In some embodiments, the cosmetic is configured to be applied to a target site. In some embodiments, the size of the cosmetic is sufficient to substantially cover the target site. In some embodiments, the cosmetic is characterized by being flexible or resilient enough to substantially adopt the 3D shape and / or configuration of the target site. In some embodiments, the cosmetic is characterized by being flexible or resilient enough to contact the target site or adhere to the target site.

[0233] In some embodiments, the cosmetic (e.g., a moist pad) is characterized by adhesion to the target site. In some embodiments, the cosmetic (e.g., a moist pad) is characterized by adhesion sufficient to stably attach or adhere to the skin (e.g., the target site). In some embodiments, the adhesion of the cosmetic (e.g., a moist pad) is sufficient to keep the pad in substantial contact with (or bonded / attached to) the skin of the target site when (i) the skin is deformed (e.g., stretched, folded, etc.) and / or (ii) at least a portion of the subject's body moves. In some embodiments, the adhesion of the cosmetic (e.g., a moist pad) is sufficient to withstand gravity and / or shear forces (e.g., due to deformation of the subject's body or the subject's skin, and / or due to friction between parts of the subject's body). In some embodiments, the adhesion is caused by capillary forces between the wet pad and the skin in contact with it.

[0234] In some embodiments, the adhesiveness of the cosmetic (e.g., a moist pad) is sufficient to substantially attach (or adhere, or bond) the pad to the target area within a time period of between 10 minutes (min) and 24 hours (h), between 10 minutes and 1 hour, between 1 hour and 24 hours, between 1 hour and 2 hours, between 2 hours and 5 hours, between 5 hours and 10 hours, between 10 hours and 24 hours, including any range in between.

[0235] In some embodiments, the moisture content of the cosmetic (e.g., moist pad) is at least 10%, at least 30%, at least 50%, at least 100%, at least 150%, at least 200%, at least 500%, at least 1000% greater than the moisture content of a dry pad of the present invention.

[0236] In some embodiments, the water content of the cosmetic (e.g., moist pad) is between 5% w / w and 5000% w / w, between 5% w / w and 10% w / w, between 10% w / w and 300% w / w, between 15% w / w and 300% w / w, between 20% w / w and 300% w / w, between 20% w / w and 30% w / w, between 25% w / w and 300% w / w, between 30% w / w and 50% w / w, between 50% w / w and 100% w / w. In some embodiments, the moisture content of the wet substrate of the present invention is at most 800%, at most 700%, at most 600%, including any range therebetween.

[0237] In some embodiments, the pads of the present invention have sufficient mechanical strength to remain substantially intact after wetting (e.g., to obtain a damp pad characterized by a moisture content as disclosed herein). In some embodiments, a substantially intact pad refers to a pad that retains at least about 80%, about 90%, about 95%, about 99% or more of one of its dimensions). In some embodiments, a substantially intact pad refers to a pad that retains about 80%, about 90%, about 95%, about 99% or more of a functional property (e.g., surface coverage, mechanical integrity, two-dimensional shape, adhesion, encapsulated cell content, cell viability, or any combination thereof). In some embodiments, sufficient mechanical strength refers to a tensile strength of at least 1 MPa, at least 2 MPa, at least 5 MPa, at least 7 MPa, at least 10 MPa, between 2 and 100 MPa, between 2 and 50 MPa, between 2 and 10 MPa, between 2 and 20 MPa, including any ranges therebetween. In some embodiments, the cosmetic (e.g., damp pad) is further employed so that it can be subsequently removed from the target site. In some embodiments, the moist pad remains substantially intact when removed or separated from the target site.

[0238] In some embodiments, a substantially intact pad of the present invention refers to a pad that substantially maintains its mechanical strength (e.g., does not tear or disintegrate) and / or size when it is wetted and / or applied to the skin and / or removed from the skin of a subject (e.g., a target site). In some embodiments, a substantially intact pad of the present invention refers to a wet pad that does not tear when it is subjected to a deformation stress equivalent to the stress generated when the wet pad is applied to and / or removed from the target site.

[0239] In some embodiments, the activating composition is a liquid composition. In some embodiments, the activating composition is an aqueous composition. In some embodiments, the activating composition is a liquid composition derived from a plant. In some embodiments, the activating composition includes plant matter. In some embodiments, the activating composition includes a plant extract. In some embodiments, the activating composition includes one or more nutrients in an amount sufficient to activate dormant cells. In some embodiments, the activating composition is capable of activating dormant cells. In some embodiments, the activating composition is capable of activating cells encapsulated in a mat of the present invention.

[0240] In some embodiments, the activation composition comprises a liquid (e.g., juice or extract) derived from a plant or plant part. In some embodiments, the activation composition comprises a cell extract (e.g., yeast extract). In some embodiments, the activation composition is mainly composed of natural compounds or natural ingredients. In some embodiments, the activation composition is essentially composed of plant-based compounds or plant-based ingredients. In some embodiments, the activation composition comprises a growth medium (e.g., MRS as known in the art).

[0241] In some embodiments, the activation composition can increase cell activation by at least 5%, at least 10%, at least 15%, at least 30%, at least 40%, at least 50%, at least 100%, at least 200%, including any range therebetween, compared to a control group. In some embodiments, the increase in cell activation is calculated based on the cell activity assessed after activating dormant cells with the activation composition, wherein the cell activity is determined as described above. In some embodiments, the control is MRS culture medium.

[0242] Non-limiting examples of plant-based ingredients and plant extracts include, but are not limited to, moringa extract, maca extract, chlorella extract, soy extract, apple syrup, apple juice, whole apples, nettle extract, wheatgrass extract, whole grapes, grape juice, grape extract, coconut juice, pomegranate juice, agave syrup, agave extract, aloe syrup or extract, beetroot juice or extract, carob extract or its syrup, green tea extract, maple syrup, calendula extract, vitania extract, cocoa extract, whole cocoa, honey, whole cucumber, cucumber juice or extract, whole dates, date syrup, whole blueberries, blueberry juice or extract, including any part, any extract, or any combination thereof.

[0243] In some embodiments, the activation composition further includes 0.01% w / w to 50% w / w of any one of nutrients, minerals (such as metal carbonates, buffers, trisodium phosphate, etc.), sugars (monosaccharides, disaccharides, oligosaccharides and / or polysaccharides), molasses, and surfactant compounds (such as Tween surfactants) or any combination thereof.

[0244] In some embodiments, the activating composition is characterized by a pH between 3 and 10, between 3 and 5, between 5 and 7, between 5 and 10, between 7 and 8, between 8 and 10, including any ranges therebetween.

[0245] Manufacturing method

[0246] As used herein, the phrase "co-electrospinning" refers to a process in which at least two immiscible polymeric solutions are electrospun from coaxial capillaries (i.e., at least two capillary distributors, one capillary placed inside another capillary, while sharing a coaxial direction) in an electrostatic field along a collector direction, the capillaries forming a spinneret. For example, the capillary can be a syringe with a metal needle, or can be a bath providing one or more capillary holes, from which the polymeric solutions can be extruded, for example, under the action of hydrostatic pressure, mechanical pressure, gas pressure and / or high voltage.

[0247] The collector is used to collect the electrospinning elements (e.g., electrospinning microtubes) thereon. This collector can be a rotating collector or a stationary (non-rotating) collector. When a rotating collector is used, this collector can be cylindrical (e.g., a drum), but the rotating collector can also be a planar geometric shape (e.g., a horizontal disc). The spinneret is usually connected to a high voltage source (e.g., a positive polarity voltage source), and the collector is grounded, thereby forming an electrostatic field between the distribution capillary (distributor) and the collector. Alternatively, the spinneret can be grounded, and the collector is connected to a high voltage source, such as a high voltage source with a negative polarity. It will be appreciated by those of ordinary skill in the art that any of the above configurations can move a positively charged jet from the spinneret to the collector. Reverse polarity can also be considered to move a negatively charged jet from the spinneret to the collector.

[0248] In order to perform electrospinning, a first polymeric solution is injected into the inner capillary of the coaxial capillary, while a second polymeric solution is injected into the outer capillary of the coaxial capillary. In some embodiments, in order to form a polymeric fiber (i.e., an electrospun microfiber as described above), the solvents of the second polymeric solution (for forming the outer shell of the polymeric fiber) and the first polymeric solution (also referred to herein as the core polymeric solution) must be immiscible with each other. In some embodiments, the first polymeric solution and the second polymeric solution are immiscible. In some embodiments, the solvent of the second polymeric solution cannot dissolve the components of the first polymeric solution, and vice versa.

[0249] In some embodiments, the first polymerization solution is an aqueous solution comprising an aqueous solvent, a water-soluble material, and a plurality of cells and / or a plurality of spores. In some embodiments, the first polymerization solution comprises between 1% w / w and 70% w / w, between 1% w / w and 10% w / w, between 1% w / w and 20% w / w, between 10% w / w and 50% w / w, between 20% w / w and 70% w / w, between 10% w / w and 70% w / w, between 30% w / w and 70% w / w, between 10% w / w and 50% w / w, between 50% w / w and 70% w / w, between 20% w / w and 50% w / w of water-soluble material.

[0250] In some embodiments, the first polymeric solution comprises between 0.01% w / w and 30% w / w, between 0.1% w / w and 30% w / w, between 0.5% w / w and 30% w / w, between 1% w / w and 30% w / w, between 1% w / w and about 20% w / w, between 1% w / w and about 30% w / w of the water-soluble polymer.

[0251] In some embodiments, the solvent of the second polymerization solution is water-immiscible and includes one or more solvents selected from THF, DMF, acetone, DMAC, chloroform, DMSO, DCM, NMP, TCE, TFE, butanol, methanol, ethanol, HFP, isopropanol, ethyl acetate, ethanolamine, pentane, ethylene glycol, diethyl ether, butyronitrile, acetonitrile, chlorobenzene, including any mixtures thereof.

[0252] In some embodiments, the solvent of the second polymerization solution comprises a mixture of THF and DMF, wherein the ratio between THF and DMF is about 7:3 (v / v or w / w). In some embodiments, the v / v or w / w ratio between THF and DMF in the first polymerization solution is between 6:3 and 8:3, between 6:3 and 6.5:3, between 6.5:3 and 7:3, between 7:3 and 7.5:3, between 7.5:3 and 8:3, including any ranges therebetween.

[0253] In some embodiments, the second polymeric solution comprises between 1% w / w and 50% w / w, between 1% w / w and 10% w / w, between 1% w / w and 20% w / w, between 10% w / w and 50% w / w, between 20% w / w and 50% w / w, between 10% w / w and 50% w / w, between 30% w / w and 50% w / w, between 20% w / w and 50% w / w of a water-insoluble polymer.

[0254] In some embodiments, the v / v ratio of the first polymeric solution and the second polymeric solution suitable for implementation in the co-electrospinning process is between 1:3 and 3:1, including any range therebetween.

[0255] The viscosities of the first polymeric solution and the second polymeric solution are compatible with each other to obtain stable electrospun fibers. In some embodiments, the viscosity of the first polymeric solution and the viscosity of the second polymeric solution are substantially the same (e.g., the difference is at most 30%, at most 20%, at most 10%, at most 5%, at most 1%, including any ranges therebetween).

[0256] According to some embodiments of the invention, the solvent of the second polymeric solution is capable of evaporating through the inner surface of the housing.Exemplary co-electrospinning solutions (first solution and second solution) are described in the Examples section herein.

[0257] In some embodiments, co-electrospinning is carried out under suitable conditions, wherein the flow rate of the first aqueous solution and / or the second solution is between 1 and 150 ml / h, between 10 and 150 ml / h, between 50 and 150 ml / h, between 1 and 50 ml / h, between 1 and 100 ml / h, or between 10 and 100 ml / h per single fiber spinning unit.

[0258] The flow rates of the first and second polymeric solutions may determine the inner and outer diameters and shell thickness of the microtubes.Non-limiting exemplary electrospinning conditions are disclosed in any of WO 2008 / 041183, WO 2009 / 104174 and WO 2009 / 104176, the contents of which are incorporated herein in their entirety.

[0259] Kits

[0260] In another aspect of the present invention, a kit is provided comprising a dry mat disclosed herein, wherein the dry mat is packaged in a container. In some embodiments, the dry mat is a mat of the present invention, for example comprising dormant / viable cells encapsulated therein. In some embodiments, the mat is a mat of the present invention, for example comprising live active cells (i.e., non-dormant cells) encapsulated therein.

[0261] In some embodiments, the container further comprises a composition (eg, an inert composition), such as for holding the mat of the present invention or a medium secreted therefrom (eg, upon activation of cells encapsulated within the mat).

[0262] In some embodiments, the dimensions of the container (e.g., width, length, height dimensions) are compatible with the corresponding dimensions of the dry mat. In some embodiments, the container includes a dry mat in a folded state. In some embodiments, the dimensions of the container (e.g., width, length, height dimensions) are compatible with the corresponding dimensions of the dry mat, wherein the dry mat is in a folded state, an unfolded state, or a partially unfolded state. In some embodiments, the container is a sealed container. In some embodiments, the container includes at least one wall defining a lumen, wherein the dimensions of the internal volume of the container are compatible with the corresponding dimensions of the dry mat. In some embodiments, the container wall is impermeable to gases (e.g., atmospheric gases, such as oxygen). In some embodiments, the container wall is impermeable to moisture. In some embodiments, the container consists of two or more containers, one inside (inside) another. In some embodiments, the container is configured to protect the mat of the present invention from exposure to the environment (e.g., oxygen and / or moisture). In some embodiments, the container is configured to greatly extend the shelf life of the mat compared to the original mat without packaging. In some embodiments, the container may include additional compartments and solutions that support activation of the cushion, and / or additional solutions for use before or after application of the matrix.

[0263] In some embodiments, the container wall is characterized by sufficient physical stability (e.g., mechanical strength) to keep the container intact under ambient conditions (also referred to herein as appropriate storage conditions). In some embodiments, appropriate storage conditions include temperatures less than 100° C., less than 50° C., less than 10° C., less than 5° C., normal atmospheric pressure or vacuum, and optionally ambient atmosphere and ultraviolet or infrared exposure for a period of time between 1 day and 5 years, between 1 month and 1 year, between 1 and 2 years, between 2 and 5 years, including any ranges therebetween.

[0264] In some embodiments, the container wall is characterized by being physically stable (e.g., substantially retaining its shape, dimensions, and mechanical properties) and / or chemically stable (e.g., chemically inert) when exposed to temperatures of at most 60°C, at most 55°C, at most 50°C, at most 40°C, at most 30°C, including any ranges therebetween.

[0265] In some embodiments, the container wall is characterized by sufficient thermal conductivity to allow efficient heat transfer from a heat source in contact with the exterior of the wall to the interior volume (or lumen) of the container enclosed by the wall. In some embodiments, the lumen of the container is filled with a liquid, and the container wall is characterized by sufficient thermal conductivity to allow efficient heat transfer from a heat source in contact with the exterior of the wall to the liquid. In some embodiments, the sufficient thermal conductivity allows the pad and liquid to be heated to a predetermined temperature (e.g., about 35°C, about 40°C, about 45°C, about 50°C, about 55°C, about 60°C, including any ranges therebetween) in a time ranging from 10 to 60 minutes, 10 to 30 minutes, 30 to 60 minutes, 30 to 50 minutes, 40 to 60 minutes, including any ranges therebetween.

[0266] In some embodiments, sufficient thermal conductivity can allow the pad and liquid to be heated to a predetermined temperature (e.g., about 35°C, about 40°C, about 45°C, about 50°C, about 55°C, about 60°C, including any ranges therebetween) in a range of between 1 and 3 hours, between 4 and 6 hours, between 6 and 8 hours, or longer.

[0267] In some embodiments, the wall comprises a laminate. In some embodiments, the wall comprises a thermoplastic or a thermosetting polymer. In some embodiments, the wall comprises a material suitable for making a pouch (e.g., polyolefins, polyvinyl alcohol (EVOH), polyethylene terephthalate (PET), polypropylene (PP), and optionally aluminum foil, including any combination thereof). Other airtight materials having the physical properties disclosed above are also well known in the art.

[0268] In some embodiments, the container is in a vacuum state or filled with an inert gas. In some embodiments, the kit (e.g., a dry mat of the present invention packaged in a container) is characterized by a shelf life of at least 1 month, at least 3 months, at least 6 months, at least 9 months, at least 12 months, at least 15 months, at least 24 months, including any ranges therebetween. In some embodiments, the shelf life of the dry mat refers to the ability of the mat to substantially maintain dormant cell viability, and / or the ability to substantially maintain physical stability and / or functional properties (including wettability, elasticity, skin adhesion, mechanical strength, etc.), wherein substantially compared to the initial cell viability physical stability and / or functional properties immediately after the mat is manufactured.

[0269] In some embodiments, the container (also referred to herein as the "first container") includes a seal. In some embodiments, the seal is configured in a closed state or an open state. In some embodiments, the seal is resealable. In some embodiments, the seal in the closed state is configured to seal the container. In some embodiments, the seal in the closed state is airtight and / or liquid / water vapor impermeable. In some embodiments, the seal is a destructible seal or a removable seal. In some embodiments, the seal is in the form of a lid or a valve. In some embodiments, the seal is configured to support liquid flow in the open state. In some embodiments, liquid can be introduced into the lumen of the container through the seal in the open state.

[0270] In some embodiments, the kit further comprises an activation composition of the present invention. In some embodiments, the activation composition is a liquid. In some embodiments, the activation composition is stored in a second container. In some embodiments, the second container is configured to hold a liquid. In some embodiments, the second container is a liquid-tight and / or airtight container.

[0271] In some embodiments, the amount of activation composition in the kit is sufficient to activate cells in a mat of the invention. In some embodiments, the amount of activation composition contained in a single kit is sufficient to activate a single mat of the invention.

[0272] In some embodiments, a sufficient amount of the activating composition (e.g., liquid composition) is between 0.1 and 10 ml, between 0.1 and 1 ml, between 0.1 and 0.5 ml, between 0.5 and 1 ml, between 1 and 2 ml, between 2 and 5 ml, between 5 and 7 ml, between 7 and 10 ml, between 10 and 15 ml, between 15 and 20 ml (including any ranges therebetween). One skilled in the art will appreciate that the exact amount of the activating composition may vary, depending on the size of the dry mat and the wetting properties of its composition.

[0273] In some embodiments, the kit is configured to contact a dry mat with an activating composition. In some embodiments, the kit is configured to contact a wet mat with an active promoting composition. In some embodiments, a seal is configured to support or enable liquid to flow (e.g., flow of a sufficient amount of the activating composition, wherein a sufficient amount is as described herein). In some embodiments, a seal is configured to facilitate the introduction of the activating composition into a first container comprising a dry mat. In some embodiments, the kit is configured to introduce the activating composition from a second container into a first container comprising a dry mat. In some embodiments, the liquid activating composition in the second container is introduced into the first container by a removable or destructible seal.

[0274] In some embodiments, the first container and the second container are combined together in a kit. In some embodiments, the kit is configured to substantially pass the liquid activation composition from the second container into the first container, such that the activation composition fills the lumen of the first container sufficiently to wet the dry mat and activate the dormant cells. In some embodiments, the seal is resealable to enable a liquid-tight seal of the first container containing the mat in contact with the liquid activation composition.

[0275] In some embodiments, the kit further comprises a heating device. In some embodiments, the heating device is compatible with the first container of the kit. In some embodiments, the heating device is used to provide a moist mat in the first container under appropriate conditions. In some embodiments, the heating device comprises a heating surface compatible with the size of at least one wall of the first container. In some embodiments, the size of the heating surface is substantially the same as the size of at least one wall of the first container. In some embodiments, the heating surface is used to heat the first container. In some embodiments, the size of the heating surface is sufficient to support the first container or connect the first container to the heating surface for a period of time described below.

[0276] In some embodiments, the heating device is a portable device configured to be applied to a target site of a subject. In some embodiments, the heating device is suitable for application to the skin of a subject. In some embodiments, the heating device is configured to generate controlled thermal emission to induce activation of encapsulated cells, wherein the thermal emission does not exceed a temperature that is harmful to the subject's skin (e.g., a temperature that does not exceed 60°C, 50°C, or 40°C in a period of time greater than 5 seconds). In some embodiments, the size of the heating device is compatible with the size of the pad and / or the size of the target site. In some embodiments, the heating device is flexible enough to substantially obtain the shape of the target site, wherein substantially means that the shape similarity with the target site is at least 80%, at least 90%, at least 95%, including any range between the two. In an exemplary embodiment, the heating device of the present invention is configured to be applied to a wet pad at the target site to induce full activation of the encapsulated cells in situ.

[0277] In some embodiments, the kit is configured to expose the mat in contact with the liquid activation composition to conditions sufficient to activate dormant cells in large quantities (also referred to herein as "appropriate conditions"). In some embodiments, appropriate conditions include providing the liquid activation composition to a predetermined temperature of about 35°C, about 40°C, about 45°C, about 50°C, about 55°C (including any range therebetween). In some embodiments, appropriate conditions include a temperature between 30 and 55°C, including any range therebetween. In some embodiments, appropriate conditions include a range of 10 to 180 minutes, 10 to 30 minutes, 30 to 60 minutes, 30 to 50 minutes, 40 to 60 minutes, 60 to 100 minutes, 100 to 120 minutes, 120 to 150 minutes, 150 to 180 minutes, 60 to 120 minutes, 60 to 180 minutes, including any range therebetween. Time period (or heating time).

[0278] In some embodiments, the kit is configured to facilitate heating of a sealed first container comprising a pad in contact with a liquid activation composition.

[0279] In some embodiments, the kit is configured to facilitate activation of cells within the cushion, thereby obtaining a ready-to-use cosmeceutical. In some embodiments, the kit is configured to support activation of dormant cells within a dry cushion by: (i) providing a liquid activation composition from a second container into a first container, thereby obtaining a moist cushion of the present invention in contact with the activation composition; (ii) by providing a moist cushion under appropriate conditions sufficient to activate the dormant cells in large quantities.

[0280] method

[0281] On the other hand, a method for obtaining a ready-to-use cosmetic of the present invention is provided, the method comprising contacting a dry pad disclosed herein with a sufficient amount of an activating composition under appropriate conditions. In some embodiments, as disclosed herein, suitable conditions are sufficient to activate dormant cells. In some embodiments, the dry pad is a dry pad of the present invention. In some embodiments, the dry pad is part of a kit of the present invention (e.g., packaged or stored in a first container). In some embodiments, the activating composition is an activating composition of the present invention. In some embodiments, the activating composition is packaged or stored in a second container.

[0282] In some embodiments, the method includes contacting the activation composition in the kit disclosed herein with a dry pad packaged or stored in the first container of the kit, thereby obtaining the instant cosmetic of the present invention. In some embodiments, contact includes destroying / removing the seal of the first container (or opening the valve), and introducing the liquid activation composition into the first container through the seal or through the valve in the open state. In some embodiments, the method further includes sealing the first container (e.g., by providing a seal or a valve in a closed state) to obtain a sealed container. In some embodiments, the method further includes exposing the sealed container to conditions suitable for activating dormant cells in large quantities (e.g., a temperature between about 30 to about 55°C, and a heating time between 10 minutes and 24 hours, as disclosed herein). In some embodiments, the method further includes removing the wet pad containing activated cells from the first container, thereby obtaining the instant cosmetic of the present invention.

[0283] On the other hand, a method for in situ generation of cellular metabolites is provided, the method comprising contacting the dry fiber material of the present invention with an activation composition under appropriate conditions sufficient to activate dormant cells, thereby inducing the in situ generation of cellular metabolites; wherein the activation composition is a liquid, which includes liquids capable of providing dormant cells from a dormant state to an active state.

[0284] In some embodiments, a method for in situ generation of cellular metabolites comprises contacting a dry mat in a kit with an activating composition in a kit, as described above.

[0285] In some embodiments, there is a method for supplementing a subject's skin with a metabolite (e.g., a cosmeceutical active metabolite), the method comprising contacting a dry pad of the kit of the present invention with an activating composition of the kit of the present invention under appropriate conditions to obtain a cosmetic comprising a metabolite; and applying the cosmetic to a target site of the subject's skin to supplement the skin with a metabolite. In some embodiments, the contact is as described above. In some embodiments, the cosmetic comprising a metabolite is a ready-to-use cosmetic of the present invention. In some embodiments, the cosmetic comprising a metabolite is a wet pad, or a solution of an activating composition comprising a metabolite.

[0286] In some embodiments, applying the cosmetic comprises attaching the cosmetic to a target site on the subject's skin. In some embodiments, the cosmetic is retained at the target site for a sufficient period of time, ranging from 1 minute to 2 hours, including any range therebetween. In some embodiments, the method further comprises subsequently removing the cosmetic from the target site.

[0287] definition

[0288] As used herein, the term "consisting essentially of means that the composition, method or structure may include additional ingredients, steps and / or parts, but the additional ingredients, steps and / or parts do not materially change the basic and novel characteristics of the claimed composition, method or structure. In addition, the term "consisting essentially of means that the composition, article (such as a cosmetic), fiber or material of the present invention consists essentially of the ingredients disclosed herein.

[0289] As used herein, the term "substantially" means at least 85%, at least 90%, at least 92%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or between 60% and 99.9%, between 70% and 80%, between 70% and 90%, between 80% and 90%, between 90% and 95%, between 95% and 99.9%, including any range or value in between.

[0290] As used herein, the term "substituent" includes hydrogen, halogen, -NO2, -CN, -OH, oxo, imino, -CONH2, -CONR'2, -CNNR'2, -CSNR'2, -CONH-OH, -CONH-NH2, -NHCOR, -NHCSR, -NHCNR, -NC(=O)OR, -NC(=O)NR', ​​-NC(=S)OR', -NC(=S)NR', ​​-SO2R', -SOR', -SR', -SO2OR', -SON(R')2, -NHNR'2, -NNR', C1-C6 haloalkyl, optionally substituted C1-C6 alkyl, -NH2, -NR'2, -NH(C C1-C6 alkyl), -N(C1-C6 alkyl)2, C1-C6 alkoxy, C1-C6 haloalkoxy, hydroxy(C1-C6 alkyl), hydroxy(C1-C6 alkoxy), alkoxy(C1-C6 alkyl), alkoxy(C1-C6 alkoxy), C1-C6 alkyl-NR'2, C1-C6 alkyl-SR', -CONH(C1-C6 alkyl), -CON(C1-C6 alkyl)2, -CO2H, -CO2R', -OCOR, -OCOR', -OC(=O)OR', -OC(=O)NR', ​​-OC(=S)OR', -OC(=S)NR', ​​or a combination thereof; wherein each R' independently represents hydrogen, or is selected from optionally substituted C1-C 10 Alkyl, optionally substituted C3-C 10 Cycloalkyl, optionally substituted C3-C 10 heterocyclyl, optionally substituted heteroaryl, optionally substituted aryl, hydroxy, amino, -NH2, -NR'2-NH(C1-C6 alkyl), -N(C1-C6 alkyl)2, C1-C6 alkoxy, C1-C6 haloalkoxy, hydroxy(C1-C6 alkyl), hydroxy(C1-C6 alkoxy), alkoxy(C1-C6 alkyl), alkoxy(C1-C6 alkoxy), C1-C6 alkyl-NR'2, C1-C6 alkyl-SR', or a combination thereof.

[0291] As used herein, the term "alkyl" refers to aliphatic hydrocarbons, which include straight chain and branched chain groups. As used herein, the term "alkyl" also includes saturated or unsaturated hydrocarbons, so the term further includes alkenyl and alkynyl.

[0292] The term "alkenyl" refers to an unsaturated alkyl group, as defined herein, having at least two carbon atoms and at least one carbon-carbon double bond. As described above, the alkenyl group may be substituted with one or more substituents or may be unsubstituted.

[0293] The term "alkynyl", as defined herein, is an unsaturated alkyl group having at least two carbon atoms and at least one carbon-carbon triple bond. As described above, the alkynyl group may be substituted with one or more substituents or may be unsubstituted.

[0294] The term "cycloalkyl" describes an all-carbon monocyclic or fused ring (ie, rings that share a pair of adjacent carbon atoms) group in which one or more of the rings do not have a completely conjugated π-electron system. As described herein, cycloalkyl groups may be substituted or unsubstituted.

[0295] The term "aryl" describes an all-carbon monocyclic or fused-ring polycyclic (ie, rings which share a pair of adjacent carbon atoms) group having a completely conjugated π-electron system. As described herein, aryl groups may be substituted or unsubstituted.

[0296] The term "alkoxy" describes O-alkyl and -O-cycloalkyl groups as defined herein. The term "aryloxy" refers to -O-aryl groups as defined herein.

[0297] Each alkyl, cycloalkyl and aryl group in the general formula herein may be substituted with one or more substituents, wherein each substituent may independently be, for example, a halide, an alkyl, an alkoxy, a cycloalkyl, a nitro, an amino, a hydroxyl, a thiol, a thioalkoxy, a carboxyl, an amide, an aryl and an aryloxy group, depending on the substituted group and its position in the molecule. In addition, additional substituents are also contemplated.

[0298] The term "halide", "halogen" or "halo" refers to fluorine, chlorine, bromine or iodine. The term "haloalkyl" refers to an alkyl group as defined herein, further substituted with one or more halides. The term "haloalkoxy" describes an alkoxy group as defined herein, further substituted with one or more halides. The term "hydroxyl" or "hydroxy" describes an -OH group. The term "mercapto" or "thiol" describes an -SH group. The term "thioalkoxy" describes -S-alkyl and -S-cycloalkyl groups, as defined herein. The term "thioaryloxy" describes -S-aryl and -S-heteroaryl groups, as defined herein. The term "amino" describes a -NR'R" group or a salt thereof, wherein R' and R" are as described herein.

[0299] "Heterocyclyl" describes a monocyclic or fused ring group with one or more atoms (such as nitrogen, oxygen and sulfur) in the ring. These rings may also have one or more double bonds. However, these rings do not have a completely conjugated π-electron system. Representative examples include piperidine, piperazine, tetrahydrofuran, tetrahydropyran, morpholino, etc.

[0300] The term "carboxy" describes a -C(O)OR' group or a carboxylate thereof, wherein R' is hydrogen, alkyl, cycloalkyl, alkenyl, aryl, heteroaryl (bonded through a ring carbon) or heterocyclyl (bonded through a ring carbon), as defined herein.

[0301] The term "carboxyl" describes a -C(O)R' group, wherein R' is as defined above. The above terms also include the thio derivatives thereof (thiocarboxyl and thiocarbonyl).

[0302] The term "thiocarbonyl" describes a -C(S)R' group, where R' is as defined above. A "thiocarboxy" refers to a -C(S)OR' group, where R' is as defined herein. A "sulfinyl" group describes a -S(O)R' group, where R' is as defined herein. A "sulfonyl" or "sulfonate" group describes a -S(O)2R' group, where R' is as defined herein.

[0303] A "carbamoyl" or "carbamate" group describes a -OC(O)NR'R" group, where R' is as defined herein and R" is as defined for R'. A "nitro" refers to a -NO2 group. As used herein, the term "amide" includes C-amides and N-amides. The term "C-amide" describes a -C(O)NR'R" terminal group or a -C(O)NR'- linking group, as defined above for these phrases, where R' and R" are as defined herein. The term "N-amide" describes a -NR"C(O)R' terminal group or a -NR'C(O)- linking group, as defined above for these phrases, where R' and R" are as defined herein.

[0304] "Cyano" or "nitrile" refers to a -CN group. The term "azo" or "diazo" describes a -N=NR' terminal group or a -N=N- linking group, as defined above for these phrases, where R' is as defined above. The term "guanidine" describes a -R'NC(N)NR"R"' terminal group or a -R'NC(N)NR"- linking group, as defined above for these phrases, where R', R" and R"' are as defined herein. As used herein, the term "azide" refers to a -N3 group. The term "sulfonamide" refers to a -S(O)2NR'R" group, where R' and R" are as defined herein.

[0305] The term "phosphono" or "phosphonate" describes a -OP(O)-(OR')2 group, where R' is as defined above. The term "phosphino" describes a -PR'R" group, where R' and R" are as defined above. The term "alkylaryl" describes an alkyl group, as defined herein, substituted with an aryl group, as described herein. An exemplary alkylaryl group is benzyl.

[0306] The term "heteroaryl" describes a monocyclic or fused ring (i.e., a ring that shares a pair of adjacent atoms) group having one or more atoms in the ring, such as nitrogen, oxygen, and sulfur, and, in addition, having a completely conjugated π-electron system. As used herein, the term "heteroaryl" refers to an aromatic ring in which at least one of the atoms forming the aromatic ring is a heteroatom. The heteroaryl ring can be composed of three, four, five, six, seven, eight, nine, and more than nine atoms. Heteroaryl groups are optionally substituted. Examples of heteroaryl groups include, but are not limited to, aromatic C containing one oxygen atom or sulfur atom, or two oxygen atoms, or two sulfur atoms, or up to four nitrogen atoms, or a combination of one oxygen atom or sulfur atom and up to two nitrogen atoms. 3-8 Heterocyclic groups, and their substitutions and benzo- and pyrido-derivatives, for example, derivatives connected by a ring-forming carbon atom. In some embodiments, heteroaryl is selected from oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, indolyl, benzimidazolyl, quinolyl, isoquinolyl, quinazolinyl or quinoxalinyl.

[0307] In some embodiments, heteroaryl is selected from pyrrolyl, furanyl (furyl), thiophenyl (thienyl), imidazolyl, pyrazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1,3-oxazolyl (oxazolyl), 1,2-oxazolyl (isoxazolyl), oxadiazolyl, 1,3-thiazolyl (thiazolyl), 1,2-thiazolyl (isothiazolyl), tetrazolyl, pyridinyl (pyr idinyl) (pyridyl), pyridazinyl, pyrimidinyl, pyrazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl, 1,2,4,5-tetrazinyl, indazolyl, indolyl, benzothiophenyl, benzofuranyl, benzothiazolyl, benzimidazolyl, benzodioxazolyl, acridinyl, quinolinyl, isoquinolinyl, quinazolinyl, quinoxalinyl, phthalazinyl, thienothiphenyl, 1,8-naphthyridinyl, other naphthyridinyl, pteridinyl or phenothiazinyl. When the heteroaryl group includes more than one ring, each additional ring is in saturated form (perhydro form) or partially unsaturated form (such as dihydro form or tetrahydro form) or maximally unsaturated (non-aromatic) form. Thus, the term heteroaryl includes bicyclic groups in which two rings are aromatic and bicyclic groups in which only one ring is aromatic. Examples of heteroaryl groups include 3H-indolyl, 2(1H)-quinolinonyl, 4-oxo-1,4-dihydroquinolinyl, 2H-1-oxoisoquinolinyl, 1,2-dihydroquinolinyl, (2H)quinolinyl N-oxide, 3,4-dihydroquinolinyl, 1,2-dihydroisoquinolinyl, 3,4-dihydro-isoquinolinyl, chromaryl. In some embodiments, heteroaryl groups are optionally substituted. In one embodiment, one or more substituents are each independently selected from halo, hydroxy, amino, cyano, nitro, alkylamino, acyl, C 1-6 -alkyl, C 1-6 -haloalkyl, C 1-6 -Hydroxyalkyl, C 1-6 -aminoalkyl, C 1-6 - alkylamino, alkylsulfenyl, alkylsulfinyl, alkylsulfonyl, sulfamoyl or trifluoromethyl.

[0308] Examples of heteroaryl groups include, but are not limited to, unsubstituted and mono- or di-substituted derivatives of furan, benzofuran, thiophene, benzothiophene, pyrrole, pyridine, indole, oxazole, benzoxazole, isoxazole, benzisoxazole, thiazole, benzothiazole, isothiazole, imidazole, benzimidazole, pyrazole, indazole, tetrazole, quinoline, isoquinoline, pyridazine, pyrimidine, purine, and pyrazine, furazan, 1,2,3-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, triazole, benzotriazole, pteridine, benzoxazole, and the like.

[0309] As used herein, the terms "halo" and "halide" are used interchangeably and refer to a halogen atom, ie, fluorine, chlorine, bromine, or iodine, also referred to herein as fluoride, chloride, bromide, and iodide.

[0310] As used herein, the term "substituted" or the term "substituent" refers to one or more than one (eg, 2, 3, 4, 5 or 6) substituents, wherein the substituents are as described herein.

[0311] General Description

[0312] As used herein, the terms "about" and "approximately" refer to ± 10%.

[0313] The terms "comprises," "comprising," "includes," "including," "having," and their cognates mean "including but not limited to." The term "consisting of" means "including and limited to." The term "consisting essentially of means that the composition, method, or structure may include additional ingredients, steps, and / or parts, but only if the additional ingredients, steps, and / or parts do not materially alter the basic and novel characteristics of the claimed composition, method, or structure.

[0314] The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any implementation described as “exemplary” is not necessarily to be construed as preferred or advantageous over other implementations and / or does not necessarily exclude the incorporation of features from other implementations.

[0315] The term "consisting essentially of" means that the composition, method or structure may include additional ingredients, steps and / or parts, but only if the additional ingredients, steps and / or parts do not materially change the basic and novel characteristics of the claimed composition, method or structure.

[0316] As used herein, “optionally” means “provided in some embodiments and not provided in other embodiments.” Any particular embodiment of the present invention may include a number of “optional” features, unless such features conflict with each other.

[0317] As used herein, the singular forms "a", "an", and "the" include plural references unless the context clearly dictates otherwise. For example, the term "a compound" or "at least one compound" may include a plurality of compounds, including mixtures thereof.

[0318] Throughout the application, various embodiments of the present invention may be represented in a range format. It should be understood that the description in a range format is only for convenience and brevity, and should not be construed as a rigid limitation on the scope of the present invention. Therefore, the description of a range should be deemed to have specifically disclosed all possible subranges and individual values ​​within the range. For example, describing a range, such as from 1 to 6, should be deemed to have specifically disclosed subranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., and individual values ​​within the range, such as 1, 2, 3, 4, 5 and 6. This applies regardless of the breadth of the range.

[0319] All numerical ranges indicated in this article are meant to include any reference numerals (decimal or integer) within the indicated range. The phrases "ranging / ranges between..." the first indicated number and the second indicated number "between" and "ranging / ranges from..." the first indicated number "to" the second indicated number are used interchangeably herein and are meant to include the first and second indicated numbers and all decimals and integers therebetween.

[0320] The term "method" as used herein refers to ways, means, techniques and procedures for completing a given task, including but not limited to ways, means, techniques and procedures known to practitioners in the fields of chemistry, electrochemistry and electronics, or ways, means, techniques and procedures developed from ways, means, techniques and procedures known to practitioners in the fields of chemistry, electrochemistry and electronics.

[0321] In those examples where a convention similar to “at least one of A, B, and C, etc.” is used, generally such interpretation is intended in a sense that one skilled in the art will understand the convention (e.g., “a system having at least one of A, B, and C” may include, but is not limited to, a system having A alone, B alone, C alone, A and B together, A and C together, B and C together, and / or A, B, and C together, etc.).

[0322] Those skilled in the art will further understand that almost any non-connective word and / or phrase presenting two or more optional terms, whether in the specification, claims or drawings, should be understood to include the possibility of one, either or both terms. For example, the phrase "A" or "B" should be understood to include the possibility of "A" or "B" or "A" and "B".

[0323] It will be appreciated that certain features of the invention described in the context of separate embodiments for clarity may also be provided in combination in a single embodiment. Conversely, various features of the invention described in a single embodiment for brevity may also be provided separately, or in any suitable subcombination, or as appropriate in any other described embodiment of the invention. Certain features described in the context of various embodiments should not be considered essential features of those embodiments unless the embodiment cannot be implemented without those elements.

[0324] Example

[0325] The inventors have successfully produced hollow electrospun polymeric fibers that enclose high-density viable cells and / or microorganisms in fibers. The outer shell of these fibers is a porous shell comprising a plurality of openings. The porous shell allows the nutrients required by the encapsulated microorganisms to diffuse from the outside of the fiber, and the products (metabolites) produced by the cells and / or microorganisms can diffuse out of the fiber at the same time. The fiber diameter can range from a few microns to hundreds of microns. In addition, the thickness of the porous shell is also controllable, ranging from tens of nanometers to about 1um, and the pore size of the shell can vary from a few nanometers to a few microns.

[0326] Furthermore, unwanted microorganisms cannot enter the fiber structure. The integrated cells / organisms are protected, so that mass transfer in and out of the fiber structure is not restricted. Thus, it can be ensured that the size of the fiber allows nutrients and by-products to be freely exchanged in the fiber. In this way, similarly, the size of the production fiber can be designed according to the type of microorganism to be encapsulated, the nutrients required and the size of the by-products.

[0327] The current technology allows the design of fiber mats suitable for various applications, not only in terms of the degree of freedom of fiber structure, but also in terms of the three-dimensional structure of the fiber mat. First, the structure of the thread (or polymeric fiber) can be controlled according to the size of the microorganisms to be encapsulated. In addition, the structure of the mat made of fibers can be oriented and designed according to the application, or can be built into multi-layer or three-dimensional structures when required.

[0328] As for the microorganisms to be encapsulated, various types of cells and / or microorganisms, such as various bacteria, yeasts, algae, mammalian and plant cells (including stem cells derived from humans and plants), can be included in high concentrations and in a live active state. In addition, enzymes and other biomolecules (such as proteins and hormones, etc.) can be included in the final fabric in an active state. The live state enables cells and microorganisms to move. As for the material of the fiber itself, both natural substances and synthetic polymers can be selected.

[0329] Furthermore, hydrophilic or hydrophobic materials, degradable / biodegradable or inert materials may be selected depending on the purpose of the final reaction. Alternatively, biocompatible and / or biodegradable materials such as medical grade components may be applied to make the pad.

[0330] Optionally, the mat disclosed herein has three application areas in the skin care cosmetics industry: various beneficial bacteria effective for overall skin health and various skin problems. It can be applied to a variety of applications, from general beauty masks to patches for treating specific skin problems.

[0331] In addition, the products produced by cells encapsulated in polymer fibers can be extracted safely and efficiently. Utilizing this effect, it can also be used as a material for bioproduction. Using this bioprocessing capability, we can build a bioproduction system to efficiently produce various additives and nutrients for cosmetics and food.

[0332] In most cases, the "probiotics" available in cosmetics have been based on (i) non-live or inert bacteria applied to the skin; (ii) lysed materials (certain non-fresh products generated after cell disruption); or (iii) processed probiotic growth media. To date, products containing inert (non-live) bacteria, disrupted cell products, or used growth media in creams or applied to the surface of masks have been the appearance of common probiotic cosmetics. In addition, the fiber mats disclosed herein may also include supportive skin nutrients and dinner foods.

[0333] On the other hand, the fiber pad disclosed at present protects live active bacteria in the fiber, providing a better environment for the skin. By enclosing dormant bacteria in the fiber, about 1000 times more bacteria can be provided than the traditional method. In addition, the cells (such as bacterial cells) are alive and once activated, they release "fresh and natural" active elements to the skin of the subject, while the bacteria contained in the fiber cannot get out.

[0334] To this end, the cells (such as bacterial cells) encapsulated in the fiber materials disclosed herein can release metabolites after activation, such as natural vitamins, acids and other various skin nutrients, which are synthesized by the cells in situ and thus (a) directly act on the actual skin conditions, keep the skin moisturized, elastic and young, and enhance resistance to UV rays and wrinkles, (b) also support existing / surviving microbial flora. In this way, by providing microorganisms from within electrospun polymeric fibers, a healthy microbial flora can be obtained, which can be easily applied directly to the skin of a subject.

[0335] The present inventors have successfully produced various fiber mats by co-electrospinning based on the non-limiting exemplary core / shell polymeric solutions listed in Table 1 below.

[0336] Table 1:

[0337]

[0338]

[0339] Composition 2 includes high MW PEG (e.g., Mw of about 400 KDa). Composition 3 includes about 700×10 6 CFU / ml, Composition 4 included about 10 6 -10 8 CFU / ml. Compositions with sugars (such as sucrose and maltose) in the second polymerisation solution below 50% w / v will result in inferior pads.

[0340] Additional stable fiber mats have been successfully produced by adding 10% to 20% w / v of a water-soluble polymer (such as PEG or hydroxyethylcellulose, abbreviated as HEC) to the first polymerizing solution instead of PVP (ingredient 2).

[0341] Furthermore, by replacing PVDF-HFP in Composition 3 with cellulose or a water-insoluble cellulose derivative (such as cellulose acetate or ethyl cellulose), the present inventors succeeded in producing a fiber mat having a cellulose-based outer shell (Composition 4).

[0342] The above-mentioned cellulosic materials (obtained from Compositions 3 and 4) have been used to obtain a formable / elastic electrospun fiber mat characterized by sufficient mechanical strength and elasticity for skin application and subsequent removal, and having a strength of up to about 10 12 CFU / cm 2 The microbial cell loading is equivalent to a w / w concentration of microbial cells in the fiber mat of up to 90%.

[0343] Furthermore, the inventors have successfully implemented a variety of water-soluble polymers in the core solution to obtain electrospun fiber mats of the present invention, whose w / w content of water-soluble polymers relative to dry matter is between about 0.2% and about 20%. The following water-soluble polymers have been implemented for electrospinning of fiber mats (w / w concentration range in the core electrospinning solution between about 0.01% and 30%), and the physical and mechanical properties of the resulting mats have been scored:

[0344]

[0345]

[0346] Furthermore, the inventors have investigated whether the thickness of the fiber mat is suitable for skin application. Many properties of the fiber mat have been scored, such as user compliance (ease of application, elasticity / formability), mechanical strength, skin adhesion, water absorption and transparency. The inventors observed that it was not possible to obtain a fiber mat with a thickness of less than 10 um (score of 0-1).

[0347] Mats with a thickness between 10 um and 1000 um (score: 10) are characterized by sufficient flexibility for handling, excellent skin adhesion and formability (substantially adopting the shape of the target site on the skin), and transparency. In addition, these mats are also characterized by excellent water permeability and liquid absorption. In addition, these mats also exhibit excellent biological activity (as determined by measuring metabolic rate). Therefore, mats with a thickness between about 10 um and about 1000 um are more excellent in cosmetic applications (e.g., as facial masks).

[0348] Mats with a thickness between 1000um and 2000um (score: 5) are characterized by reduced flexibility (however, still flexible, providing a comfortable feel when applied to the skin). Compared to mats between 10um and 1000um, transparency is reduced - the fabric is not transparent, and biological activity is also reduced (but still very active). In addition, these mats are characterized by reduced water permeability and increased liquid absorption compared to mats between 10um and 1000um. Therefore, mats with a thickness between about 1000um and about 2000um are suitable for cosmetic applications (e.g., as a facial mask).

[0349] Pads with a thickness of more than 2000um (score 0-1) are characterized by low flexibility (difficult to handle). These pads do not adhere well to the skin, are not transparent, and have reduced biological activity. In addition, these pads are characterized by reduced water permeability and increased liquid absorption compared to pads of 1000um-2000um.

[0350] Exemplary mats of the present invention are characterized by a water absorption of up to about 700% relative to the initial dry weight of the mat.

[0351] In addition, the inventors also tested exemplary mats with the following characteristics: (i) different cell loadings; (ii) different fiber diameters; (iii) different fiber shell pore sizes / porosities. The w / w cell concentration in the mat was calculated as follows:

[0352]

[0353] The results are summarized as follows:

[0354]

[0355]

[0356]

[0357]

[0358] Based on the above, the inventors believe that an exemplary cosmetic product of the present invention having a high loading of dormant or active cells is characterized by: (i) the cell loading w / w in the fiber material is at most about 90-95%; (ii) the average shell pore size and porosity supporting bacterial viability and further activation thereof are between 10-500 nm and at least about 70%, respectively; (iii) the average fiber cross-section is less than 500 um, or between about 10 and about 300 um.

[0359] Although the present invention has been described in conjunction with its specific embodiments, many alternatives, modifications and variations will be apparent to those skilled in the art. Therefore, the present invention is intended to include all such alternatives, modifications and variations within the spirit and broad scope of the appended claims.

Claims

1. A fiber mat comprising a plurality of electrospun fibers, wherein each of the electrospun fibers comprises a shell encapsulating a core, wherein: The fiber mat is characterized by a thickness between 10 and 2000 um; The core comprises: (i) a water-soluble material comprising a water-soluble polymer; and (ii) a plurality of cells; The shell is a porous shell comprising a water-insoluble polymer; and wherein the loading amount of the plurality of cells in the fiber mat is at most 10 13 CFU / cm 2 .

2. The fiber mat according to claim 1, wherein the plurality of cells are selected from microbial cells, microbial spores, microorganisms or a combination thereof; optionally wherein the microbial cells or microbial spores comprise one or more bacteria, fungi or both.

3. The fiber mat of claim 1 or 2, wherein the plurality of cells within the mat has a dry weight / weight (w / w) concentration of at most about 95%.

4. The fiber mat according to claim 3, wherein the w / w concentration of the plurality of cells in the mat is at most 90%, optionally wherein the plurality of cells are dormant cells.

5. The fiber mat according to any one of claims 1 to 4, wherein the average cross-section of the electrospun fibers within the fiber mat is between 1 and 500 um.

6. The fiber mat of claim 5, wherein the average cross-section of the electrospun fibers within the fiber mat is between 10 and 300 um.

7. The fiber mat according to any one of claims 1 to 6, wherein the loading amount of the plurality of cells in the fiber mat is 10 9 and 10 12 CFU / cm 2 between.

8. The fiber mat according to any one of claims 1 to 7, wherein the fiber mat consists mainly of biocompatible materials or cosmeceutical grade materials.

9. The fiber mat of any one of claims 1 to 8, wherein the shell comprises at least 50% by dry weight of the water-insoluble polymer, and optionally further comprises a water-soluble polymer.

10. The fiber mat according to any one of claims 1 to 9, wherein the water-insoluble polymer comprises a water-insoluble polysaccharide, a fluoropolymer or PVDF-HFP, including any combination and any copolymer thereof.

11. The fiber mat of claim 10, wherein the water-insoluble polysaccharide comprises cellulose, a water-insoluble cellulose derivative, including any combination and any copolymer thereof.

12. The fiber mat of claim 11, wherein the water-insoluble cellulose derivative comprises cellulose acetate, cellulose acetate phthalate, methyl cellulose, ethyl cellulose, ethyl methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, hydroxypropyl methyl cellulose, including any combination and any copolymer thereof.

13. The fiber mat according to any one of claims 1 to 12, wherein the water-soluble polymer is selected from water-soluble polysaccharides, polyols, polyvinyl alcohol, polyalkylene oxide, PVP, polyethers, including any copolymers and any combination thereof.

14. The fiber mat according to any one of claims 1 to 13, wherein the water-soluble material further comprises monosaccharides, disaccharides, oligosaccharides or any combination thereof.

15. The fiber mat according to any one of claims 1 to 14, wherein the fiber mat is formable and characterized by a water absorption capacity of up to 1000% relative to the dry weight of the fiber mat.

16. The fiber mat of claim 14, wherein the fiber mat is in a moist form and is characterized by adhesion to human skin.

17. The fiber mat according to any one of claims 1 to 15, further comprising a plant extract, a bacterial metabolite, a fungal metabolite, or any combination thereof.

18. The fiber mat according to any one of claims 1 to 16, wherein the fiber mat is characterized by a water content of less than 10%, and wherein the dormant cells maintain their viability in the fiber mat for at least 3 months.

19. The fiber mat of any one of claims 1 to 17, wherein the average cross-section of the electrospun fibers within the fiber mat is between about 10 and about 200 um; wherein the w / w concentration of the plurality of cells within the mat is at most 90%, or wherein the loading of the plurality of cells within the fiber mat is at most 10 12 CFU / cm 2 ; wherein the shell comprises cellulose or the water-insoluble cellulose derivative; and wherein the core comprises (i) at least one of a monosaccharide, a disaccharide and an oligosaccharide; and (ii) the water-soluble polymer selected from polyalkylene oxide and the water-soluble polysaccharide.

20. The fiber mat of claim 19, wherein the water-soluble polysaccharide is a water-soluble gum, and wherein the polyalkylene oxide is PEG.

21. A fibre mat according to any one of claims 1 to 20 in the form of a non-woven uniform layer.

22. A fibre mat according to any one of claims 1 to 21 in the form of a sphere.

23. A fibrous mat according to any one of claims 1 to 22 in the form of a topical product configured to be applied to a target site on the skin of a subject.

24. The fiber mat of claim 23, wherein the topical product is further configured for subsequent removal from the target site, and wherein the topical product has sufficient mechanical strength to remain intact upon its removal.

25. The fiber mat of claim 23, wherein the topical product is characterized by a tensile strength of at least 1 MPa.

26. A fibre mat as claimed in claims 23 to 25, wherein the topical product is configured to substantially adopt the shape of the target site.

27. The fiber mat of any one of claims 23 to 26, wherein the topical product has a length dimension, a width dimension, or both that are substantially compatible with the dimensions of the target site.

28. The fiber mat of any one of claims 23 to 27, wherein the topical product is configured to stably adhere to the target site for a predetermined period of time.

29. A kit comprising a fiber mat according to any one of claims 1 to 28 packaged in a container, wherein the fiber mat is characterized by a moisture content of at most 10%, and wherein the walls of the container are water-impermeable and substantially oxygen-impermeable.

30. The kit of claim 29, wherein the walls of the container remain stable at temperatures up to 60°C and are characterized by adequate heat conduction capabilities.

31. The kit of claim 29 or 30, further comprising a watertight container comprising an activation composition, wherein the plurality of cells within the fiber mat are substantially in a dormant state, and wherein the activation composition is capable of causing the plurality of cells to enter an active state from the dormant state.

32. The kit of claim 31 , wherein the activating composition is a liquid comprising an effective amount of a plant-based compound or plant extract, and optionally any of nutrients, minerals, monosaccharides, disaccharides, oligosaccharides, polysaccharides, surface active compounds, or any combination thereof.

33. The kit of claim 31 or 32, wherein the activating composition is characterized by a pH value between 3 and 10.

34. The kit of claim 32, wherein the effective amount is sufficient to activate dormant cells when the activating composition is contacted with the fiber mat under operable conditions.

35. The kit of claim 34, wherein the operable conditions comprise a temperature between about 30 and about 55°C.

36. A kit according to any one of claims 29 to 35, wherein the wall of the container defines a lumen configured to hold a volume of liquid; and wherein the container further comprises a seal, and wherein the seal is a removable seal or a breakable seal.

37. A kit according to claim 36, wherein the seal is characterized by an open state and a closed state; wherein the seal is in the form of a valve, and wherein in the open state, the valve is configured to communicate with the fluid of the watertight container and support the flow of liquid from the watertight container into the tubular cavity, and wherein in the closed state, the valve is configured to seal the container.

38. A kit according to any one of claims 29 to 37, further comprising a heating device.

39. The kit of any one of claims 31 to 38, further comprising instructions for contacting the fiber mat with the activating composition to obtain a moist mat and applying the moist mat to the skin of a subject.

40. The kit of any one of claims 31 to 38, further comprising any of the following: (i) instructions for contacting the fiber mat with the activating composition to obtain a moist mat and applying the extract in the moist mat to the skin of a subject; and (ii) further comprising instructions for heating the moist mat, and wherein the heating is performed before or after skin application.

41. The kit of claim 40, wherein the heating is performed by the heating device.

42. A method for in situ generation of cellular metabolites, the method comprising contacting the fiber mat of any one of claims 1 to 28 with an activating composition under appropriate conditions sufficient to activate dormant cells, thereby inducing the in situ generation of the cellular metabolites; wherein the activating composition is a liquid that can cause the dormant cells to enter an active state from a dormant state.

43. A method comprising: providing a kit according to any one of claims 29 to 41 and contacting the fiber mat with an activating composition under suitable conditions to obtain a topical product comprising a metabolite; as well as The product is applied to a target area of ​​the subject's skin, thereby replenishing the skin with the metabolite.

44. The method of claim 43, wherein the topical product comprises a pad in a moist state.

45. The method according to any one of claims 43 to 44, wherein the activating composition comprises an effective amount of a plant-based compound or plant extract, and optionally any of nutrients, minerals, sugars, surface-active compounds or any combination thereof.

46. ​​The method of any one of claims 43 to 45, wherein the activating composition is characterized by a pH value between 3 and 10.

47. The method of any one of claims 43 to 46, wherein contacting comprises soaking the fiber mat in the activating composition.

48. The method of any one of claims 43 to 47, wherein suitable conditions include a temperature of about 30 to about 55°C.

49. The method of any one of claims 43 to 48, wherein appropriate conditions comprise contacting the moist pad with (i) the heating device, (ii) the subject's skin, or both (i) and (ii).

50. The method of any one of claims 43 to 47, wherein the applying is under conditions sufficient to provide the moist mat to a temperature between about 30 to about 55°C.

51. The method of claim 50, wherein the providing is performed in situ on the skin of the subject.

52. The method of claim 50, wherein the providing is by contacting the moist pad with a heating device, and wherein the contacting is performed in situ on the subject's skin.

53. A fibrous substrate comprising polymeric fibers, each polymeric fiber being an electrospun fiber, comprising a sheath enclosing a core, in: The core comprises a plurality of cells and a water-soluble material; The shell comprises a water-insoluble polymer; The average cross-section of the polymeric fibers is between 1 and 500 um; and wherein the loading amount of the plurality of cells in the fiber substrate is at least 2 10E5 units.

54. The fibrous substrate according to claim 53, wherein the water-soluble material comprises a water-soluble polymer selected from the group consisting of polysaccharides, polyols, polyvinyl alcohols, polyethers, and any combination thereof.

55. The fibrous substrate according to claim 53 or 54, wherein the water-soluble material further comprises monosaccharides, disaccharides, oligosaccharides or any combination thereof.

56. The fibrous substrate of any one of claims 53 to 55, wherein the w / w ratio of the shell and the core within the fiber is between 50:1 and 1:50, and wherein the dry w / w concentration of the plurality of cells within the fibrous substrate is between 40% and 98%.

57. The fibrous substrate according to any one of claims 53 to 56, wherein the fibrous substrate is in the form of a fibrous mat.

58. The polymeric fiber of claim 57, wherein the fiber mat is an electrospun mat characterized in that The thickness is between 10 and 2000um.

59. The fibrous substrate according to any one of claims 53 to 58, wherein the water-insoluble polymer is selected from cellulose, fluoropolymers, PVDF-HFP, PVP, PCL, PLA, PGA, polystyrene, PES, acrylate polymers, water-insoluble polysaccharides, water-insoluble cellulose derivatives, including any combination and any copolymers thereof.

60. The fibrous substrate of any one of claims 53 to 59, wherein the water-insoluble polymer constitutes at least 50% by dry weight of the shell; and wherein the shell is characterized by a plurality of pores, the pores being characterized by an average pore size between 10 and 500 nm.

61. The fibrous substrate of any one of claims 53 to 60, wherein the shell is characterized by a thickness between 10 nm and about 10 um.

62. A fibrous substrate according to any one of claims 53 to 61, wherein the water-insoluble polymer is characterized by a solubility of at least 5% w / w in a solvent selected from the group consisting of THF, DMF, acetone, DMAC, chloroform, DMSO, DCM, NMP, TCE, TFE, butanol, methanol, ethanol, HFP, isopropanol, ethyl acetate, ethanolamine, pentane, ethylene glycol, diethyl ether, butyronitrile, acetonitrile, chlorobenzene, including any combination thereof.

63. The fibrous substrate according to any one of claims 53 to 62, wherein the core further comprises at least one additional ingredient selected from active ingredients, cell nutritional ingredients, or both.

64. The fibrous substrate of any one of claims 53 to 63, wherein the viability of the plurality of cells within the polymeric fibers is maintained for at least 2 weeks.